Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3000242	li-tau	ng/l (ng/l)	1637	1669	0.36%
3000242	li-tau	— (—)	675	691	100.00%	Distribution not available
3000242	li-tauproteiini,likvor	ng/l (ng/l)	6	6	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

N06DA Anticholinesterases

876

456

15.94

307.65

1.0

394.13

282.80

ng/l

11.86

649

278

Symptoms and signs involving cognition, perception, emotional state and behaviour

1447

712

14.17

307.65

1.0

327.01

338.80

ng/l

0.17

1166

381

Alzheimer’s disease, strict definition

687

313

19.10

307.65

1.0

418.51

271.73

ng/l

17.02

521

177

Alzheimer’s disease (Early onset)

238

68.97

307.65

1.0

411.35

229.79

ng/l

7.43

189

Use of donepezil

511

351

14.70

307.65

1.0

421.87

298.76

ng/l

10.03

387

206

Dementia, including avohilmo

1177

427

19.94

307.65

1.0

365.95

271.67

ng/l

4.44

873

257

Any dementia, excluding more controls

968

326

21.57

307.65

1.0

1.1

387.34

310.77

ng/l

1.90

733

192

Dementia in Alzheimer disease

316

122

22.66

307.65

1.0

416.45

238.33

ng/l

8.99

196

Implicit Sepsis

945

1172

6.19

307.65

1.0

286.02

371.69

ng/l

1.69

772

753

Alzheimer’s disease (Late onset)

476

287

14.53

307.65

1.0

429.72

275.99

ng/l

13.83

348

162

Any mental disorder

961

719

6.77

307.65

1.0

336.03

331.86

ng/l

0.03

702

473

Normal-pressure hydrocephalus

341

46.87

307.65

1.1

1.0

244.91

348.68

ng/l

1.77

103

Use of other anti-dementia drugs

507

393

11.09

307.65

1.0

418.19

312.19

ng/l

6.99

366

230

Other degenerative diseases of the nervous system

940

145

51.49

307.65

1.0

372.29

385.77

ng/l

0.08

722

111

Hydrocephalus

366

136

30.34

307.65

1.1

1.0

246.42

341.92

ng/l

2.13

114

Alzheimer disease

783

392

15.34

307.65

1.0

408.94

270.94

ng/l

18.56

581

229

Other mental disorders due to brain damage and dysfunction and to physical disease

398

125

34.57

307.65

1.0

303.80

221.85

ng/l

4.51

276

Psychiatric diseases

831

448

9.39

307.65

1.0

333.33

350.41

ng/l

0.07

602

301

Implicit Sepsis

1162

1000

8.67

307.65

1.0

286.26

393.73

ng/l

1.76

955

605

Alzheimer disease, including avohilmo

891

424

15.52

307.65

1.0

403.88

273.27

ng/l

15.60

654

252

Other symptoms and signs involving cognitive functions and awareness

1377

488

27.17

307.65

1.0

324.74

365.40

ng/l

0.66

1148

257

Unspecific neurodegenerative disorder

1053

422

17.92

307.65

1.0

384.98

284.43

ng/l

4.72

772

258

Degenerative diseases of the nervous system

963

432

17.27

307.65

1.0

379.96

286.71

ng/l

8.50

733

261

Use of memantine

507

393

11.09

307.65

1.0

418.19

312.19

ng/l

6.99

366

230

Dementia

1123

353

23.05

307.65

1.0

373.02

274.91

ng/l

3.63

833

214

Use of anticholinesterases

876

456

15.94

307.65

1.0

394.13

282.80

ng/l

11.86

649

278

Condition for Implicit Sepsis (Organ dysfunction codes)

1376

685

14.17

307.65

1.0

297.21

415.51

ng/l

0.98

1118

367

Alzheimer disease, excluding more controls

748

191.80

307.65

1.0

1.1

402.05

488.61

ng/l

0.17

562

Condition for Implicit Sepsis (Organ dysfunction codes)

1329

802

11.97

307.65

1.0

290.72

410.03

ng/l

1.31

1088

445

Any dementia

980

431

16.59

307.65

1.0

388.55

267.67

ng/l

13.35

740

251

Organic, including symptomatic, mental disorders

1325

443

22.39

307.65

1.0

360.90

258.68

ng/l

5.61

968

278

Use of rivastigmine

316

286

11.53

299.94

1.0

373.18

337.85

ng/l

0.91

234

165

Depression or dysthymia

420

254

9.20

250.06

1.0

271.57

440.50

ng/l

0.54

290

168

Intracranial trauma

346

265

9.25

238.65

1.0

396.73

324.13

ng/l

0.27

231

204

Mood disorders, excluding more controls

588

701

5.05

224.31

1.0

248.20

331.52

ng/l

0.83

420

467

Memory loss

175

19.50

222.99

1.0

311.37

224.33

ng/l

3.32

137

Other neurological diseases

676

1353

3.97

215.71

1.0

354.29

331.36

ng/l

0.12

367

1050

Unspecified dementia

168

21.59

209.26

1.0

333.25

248.16

ng/l

2.03

137

Circumscribed brain atrophy

121

47.48

203.48

1.0

277.93

201.00

ng/l

2.83

100

Neurological diseases

436

324

6.80

199.44

1.0

322.99

312.75

ng/l

0.13

306

247

Concussion

271

265

8.41

189.06

1.0

426.05

324.13

ng/l

0.32

186

204

Implicit viral Sepsis

298

475

6.38

177.81

1.1

1.0

287.57

345.69

ng/l

1.56

232

289

Parkinson's disease, excluding more controls

114

36.42

174.60

1.0

1.1

248.47

468.40

ng/l

0.59

Symptoms and signs involving the nervous and musculoskeletal systems

517

1338

3.91

173.70

1.0

276.09

358.57

ng/l

1.89

341

958

Dizziness and giddiness

409

670

4.87

169.28

1.0

301.51

348.38

ng/l

1.31

270

355

Parkinson's disease, strict definition, excluding more controls

102

34.05

154.65

1.0

1.1

246.33

479.00

ng/l

0.61

Implicit bacterial Sepsis

390

792

4.31

142.80

1.0

268.38

353.12

ng/l

6.23

310

487

Recurrent or chronic depression

200

153

9.26

138.24

1.0

246.78

480.14

ng/l

0.46

132

106

Other and unspecified degenerative diseases of nervous system

27.28

135.36

1.1

1.0

290.39

242.26

ng/l

0.59

Other antidepressants

654

1050

3.21

133.25

1.0

286.77

377.96

ng/l

1.86

446

766

Undefined dementia

168

181

8.78

127.47

1.0

333.25

328.21

ng/l

0.06

137

Delirium, not induced by alcohol and other psychoactive substances

126

108

11.90

123.65

1.0

369.63

226.16

ng/l

1.73

Alzheimer’s disease (Atypical or mixed)

125

105

12.13

123.52

1.0

1.1

355.31

268.81

ng/l

1.69

Implicit bacterial Sepsis

333

742

4.02

112.72

1.0

274.46

342.94

ng/l

5.31

263

459

Anxiety disorders, excluding more controls

374

639

3.83

107.28

1.0

253.90

321.34

ng/l

0.56

288

430

Other symptoms and signs involving the nervous and musculoskeletal systems

328

901

3.68

101.43

1.0

273.81

325.98

ng/l

3.17

221

647

Use of galantamine

130

157

8.59

100.13

1.1

1.0

395.39

324.93

ng/l

1.41

Abnormalities of gait and mobility

164

262

6.44

98.19

1.0

263.45

351.54

ng/l

0.93

170

Viral Sepsis

188

351

5.44

95.40

1.1

1.0

292.94

356.91

ng/l

0.96

140

210

Vascular dementia

12.63

95.04

1.0

340.39

250.17

ng/l

1.84

Implicit viral Sepsis

187

351

5.41

94.34

1.1

1.0

292.94

356.91

ng/l

0.96

140

210

Bacterial Sepsis

336

819

3.54

94.05

1.0

275.79

348.49

ng/l

4.61

265

506

Selective serotonin reuptake inhibitors

561

1050

2.80

92.55

1.0

290.05

377.96

ng/l

1.73

381

766

Schizophrenia or delusion, excluding more controls

159

266

5.96

89.17

1.0

274.39

245.50

ng/l

0.76

126

173

Dementia in other diseases classified elsewhere

16.37

86.74

1.0

271.23

220.07

ng/l

0.83

Medical observation and evaluation for suspected diseases and conditions

387

605

3.29

82.11

1.0

305.36

334.64

ng/l

0.81

236

474

Traumatic subdural haemorrhage

10.41

80.38

1.0

291.16

304.92

ng/l

0.15

Mood [affective] disorders

593

1602

2.41

78.06

1.0

248.31

357.58

ng/l

4.85

425

1155

Mood disorders

593

1606

2.40

77.35

1.0

247.54

358.36

ng/l

5.01

424

1160

Depression

540

1539

2.39

70.63

1.0

253.00

355.01

ng/l

4.12

382

1116

Substance abuse, excluding more controls

237

565

3.59

68.32

1.0

286.31

336.67

ng/l

0.32

175

382

Malaise and fatigue

337

960

2.85

65.15

1.0

304.38

383.91

ng/l

1.17

240

674

Nonorganic sleeping disorders, excluding more controls

132

7.26

64.61

1.0

238.63

250.87

ng/l

0.21

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

135

7.08

64.05

1.0

269.33

339.66

ng/l

1.47

Extrapyramidal and movement disorders

285

965

2.98

63.07

1.0

250.69

341.93

ng/l

8.54

196

666

Vascular dementia (subcortical)

17.66

62.03

1.1

1.0

348.63

245.24

ng/l

1.34

Other and unspecified hydrocephalus

16.95

61.21

1.1

1.0

236.10

282.22

ng/l

0.54

Neurological diseases, wide definition

104

9.53

59.98

1.0

269.45

259.27

ng/l

0.08

Injuries to the head

580

1696

2.11

55.52

1.0

354.23

322.72

ng/l

0.20

407

1218

Epilepsy

203

612

3.33

54.38

1.0

282.38

334.82

ng/l

1.73

153

434

Psychotic depression

23.25

53.75

1.0

1.1

177.56

238.67

ng/l

0.59

Postprocedural disorders of nervous system

8.87

53.55

1.0

331.86

298.67

ng/l

0.30

General examination and investigation of persons without complaint and reported diagnosis

319

605

2.76

51.71

1.0

269.54

334.64

ng/l

3.38

212

474

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

100

183

5.47

51.59

1.0

246.97

244.71

ng/l

0.04

126

Benzodiazepine use

533

1758

2.10

51.55

1.0

289.10

342.60

ng/l

1.52

388

1242

Depression medications

128

133

4.86

43.95

1.0

260.51

336.51

ng/l

1.83

105

Intracranial injury

317

1276

2.36

43.90

1.0

410.49

328.98

ng/l

0.29

207

887

Convulsions, not elsewhere classified

146

413

3.52

42.57

1.0

282.64

329.10

ng/l

1.18

109

296

Personality disorders, excluding more controls

181

5.00

42.08

1.0

203.73

244.33

ng/l

1.59

123

Use of levodopa decarboxylase inhibitor

128

354

3.68

39.69

1.0

256.57

329.15

ng/l

2.51

229

General symptoms and signs

501

1265

1.99

39.21

1.0

284.18

357.92

ng/l

1.68

353

917

Bipolar affective disorders

108

268

4.06

38.92

1.0

217.59

342.23

ng/l

6.31

205

Syncope and collapse

259

910

2.45

38.19

1.0

276.20

347.34

ng/l

3.86

174

638

Kela-code for severe mental illness

202

756

2.69

37.27

1.0

235.67

319.75

ng/l

5.09

150

545

Unspecified mental disorder

216

842

2.58

36.70

1.0

238.51

318.37

ng/l

5.13

162

602

Persons encountering health services for examination and investigation

289

605

2.40

35.57

1.0

299.18

334.64

ng/l

1.01

194

474

Fall on same level

528

1551

1.86

35.07

1.0

309.10

337.57

ng/l

0.55

380

1127

Other special examinations and investigations of persons without complaint or reported diagnosis

285

605

2.39

34.88

1.0

314.67

334.64

ng/l

0.43

192

474

Other extrapyramidal and movement disorders in other diseases

164

578

2.87

34.06

1.0

269.89

337.47

ng/l

3.45

115

404

Focal epilepsy

143

467

3.09

33.97

1.0

277.28

316.05

ng/l

1.06

103

319

Focal epilepsy, mode (most common among epilepsy diagnosis)

129

412

3.16

31.88

1.0

283.54

316.05

ng/l

0.74

280

Examination and observation for other reasons

247

605

2.37

30.92

1.0

279.51

334.64

ng/l

2.17

164

474

Other degenerative diseases of the basal ganglia

9.00

30.82

1.1

1.0

217.60

324.14

ng/l

1.47

Other symptoms and signs involving general sensations and perceptions

10.84

30.50

1.0

300.63

261.27

ng/l

0.43

Focal epilepsy, strict definition

132

442

3.01

30.10

1.0

281.54

312.23

ng/l

0.70

302

Anxiety (asthma-related co-morbidities)

245

848

2.24

29.16

1.0

243.56

364.26

ng/l

2.16

187

624

Communicating hydrocephalus

9.82

29.02

1.2

1.0

284.50

267.32

ng/l

0.07

Parkinson's disease, including avohilmo

127

428

3.00

28.73

1.0

251.26

326.56

ng/l

3.33

283

Non-selective monoamine reuptake inhibitors

185

733

2.45

28.04

1.0

263.02

397.53

ng/l

2.04

128

542

Other anxiety disorders

187

682

2.39

26.34

1.0

254.36

321.55

ng/l

2.86

140

495

Implicit fungal Sepsis

109

5.03

25.38

1.0

261.84

362.78

ng/l

2.07

Headache

280

1120

2.00

25.20

1.0

280.88

366.27

ng/l

1.73

193

814

Infections, IBD-co-morbidities

6.48

25.16

1.0

277.93

262.29

ng/l

0.13

Schizophrenia, schizotypal and delusional disorders

160

652

2.47

24.98

1.0

274.39

314.94

ng/l

1.11

126

469

Schizophrenia or delusion

159

647

2.47

24.91

1.0

274.39

316.07

ng/l

1.15

126

467

Hypothyroidism (congenital or acquired)

132

3.82

24.64

1.0

310.80

337.91

ng/l

0.27

104

Episodal and paroxysmal disorders

451

1311

1.75

24.50

1.0

291.59

341.04

ng/l

2.70

312

934

Other disorders of urethra and urinary system

332

1283

1.87

24.12

1.0

296.45

363.97

ng/l

1.33

233

893

Cerebrovascular diseases

399

1589

1.77

24.01

1.0

306.50

341.84

ng/l

0.70

270

1135

Other and unspecified nonorganic psychotic disorders

311

3.14

23.93

1.0

265.59

310.20

ng/l

1.08

219

Hypothyroidism and >3 levothyroxin purchases

131

3.77

23.67

1.0

313.34

337.91

ng/l

0.24

104

Hypothyroidism, levothyroxine purchases

131

3.77

23.67

1.0

313.34

337.91

ng/l

0.24

104

Parkinson's disease

114

406

2.84

23.43

1.0

248.47

327.18

ng/l

3.22

265

Progressive vascular leukoencephalopathy

6.48

23.16

1.1

1.0

245.96

306.74

ng/l

0.82

Constipation

427

1747

1.70

22.11

1.0

289.54

346.40

ng/l

1.57

312

1230

STROKE

313

1162

1.84

21.23

1.0

295.03

364.50

ng/l

1.31

229

849

All anxiety disorders

245

996

1.95

20.51

1.0

243.56

347.79

ng/l

2.11

187

723

Manic episode

8.09

20.07

1.0

213.55

363.68

ng/l

1.29

Parkinson's disease, strict definition

102

373

2.76

20.02

1.0

246.33

332.45

ng/l

3.24

241

Focal brain injury

7.31

19.92

1.0

257.88

272.52

ng/l

0.13

severe traumatic brain injury, does not include concussion

132

555

2.40

19.40

1.0

273.92

318.71

ng/l

1.22

372

Disorders of thyroid, IBD co-morbidities

5.38

18.84

1.0

280.35

259.27

ng/l

0.16

Covid-19 confirmed case

178

857

2.09

18.80

1.1

1.0

297.62

333.16

ng/l

1.15

125

580

Abnormal involuntary movements

273

2.99

18.48

1.0

263.14

335.45

ng/l

1.56

187

Anxiety disorders

377

1582

1.66

18.34

1.0

253.62

345.82

ng/l

3.39

290

1128

Neurotic, stress-related and somatoform disorders

371

1563

1.66

18.08

1.0

252.98

344.36

ng/l

3.30

284

1118

Nonorganic sleeping disorders

353

2.71

18.08

1.0

238.63

313.49

ng/l

2.96

251

Metabolic disorders

421

1593

1.62

17.81

1.0

368.00

327.26

ng/l

0.20

306

1120

Open wound of head

241

1266

1.84

17.63

1.0

295.24

325.06

ng/l

0.93

170

892

Alcohol abuse, main dg, excluding more controls

137

3.82

17.45

1.0

1.1

253.32

243.94

ng/l

0.12

Care involving use of rehabilitation procedures

305

1655

1.70

16.88

1.0

390.45

316.89

ng/l

0.32

256

1157

Provisional assignment of new diseases of uncertain etiology

224

1215

1.85

16.69

1.1

1.0

287.67

356.53

ng/l

1.28

162

833

Codes for special purposes

224

1217

1.84

16.61

1.1

1.0

287.67

357.22

ng/l

1.30

162

834

Other dorsopathies, not elsewhere classified

396

1283

1.62

16.35

1.0

286.70

363.01

ng/l

1.78

263

948

Sequelae of injuries of head

105

4.16

16.10

1.0

273.39

257.95

ng/l

0.14

Dorsalgia

387

1283

1.62

16.09

1.0

274.17

363.01

ng/l

2.34

252

948

Lower back pain or/and sciatica

440

1857

1.55

15.91

1.0

268.34

343.66

ng/l

2.90

282

1354

Other intervertebral disc disorders

349

1281

1.64

15.83

1.0

269.51

363.23

ng/l

2.55

242

947

Speech disturbances, not elsewhere classified

202

3.16

15.74

1.1

1.0

257.15

300.93

ng/l

0.65

125

Spondylopathies

349

1275

1.64

15.63

1.0

276.41

363.92

ng/l

2.31

222

944

Disorders of lipoprotein metabolism and other lipidaemias

397

1555

1.59

15.63

1.0

279.38

329.25

ng/l

3.50

301

1093

Superficial injury of head

109

467

2.35

15.44

1.0

292.99

338.56

ng/l

0.78

325

Falls/tendency to fall

416

1324

1.58

15.30

1.0

389.07

316.71

ng/l

0.39

298

960

Monoamine oxidase A inhibitors

185

3.21

15.28

1.1

1.0

333.20

362.01

ng/l

0.26

139

Schizoaffective disorder

133

3.65

15.07

1.0

207.11

297.67

ng/l

2.71

Anaemias

131

3.20

14.69

1.0

306.82

337.91

ng/l

0.33

104

Follow-up examination after treatment for conditions other than malignant neoplasms

155

500

2.06

14.69

1.0

547.31

331.09

ng/l

0.46

115

396

Persons encountering health services for specific procedures and health care

436

1713

1.53

14.62

1.0

381.31

315.37

ng/l

0.39

337

1197

Cerebrovascular diseases (FINNGEN)

173

630

1.95

14.37

1.0

293.27

341.83

ng/l

1.32

131

482

Low back pain

294

1282

1.65

14.08

1.0

269.68

363.01

ng/l

2.47

195

948

Generalized anxiety disorder

169

3.21

14.03

1.0

255.88

323.92

ng/l

1.33

116

Parasetamol

274

812

1.71

14.00

1.0

276.83

329.55

ng/l

2.62

189

629

Pure hypercholesterolaemia

364

1517

1.57

13.98

1.0

269.60

330.55

ng/l

5.32

273

1064

Other disorders of ear

410

1766

1.52

13.79

1.0

398.01

316.10

ng/l

0.43

286

1274

Poisoning by medicine

368

2.43

13.71

1.0

249.80

326.62

ng/l

2.86

266

Sleep disorders (combined)

446

1558

1.51

13.57

1.0

358.59

336.79

ng/l

0.10

321

1097

Poisoning by drugs, medicaments and biological substances

415

2.32

13.40

1.0

250.62

324.45

ng/l

2.84

298

Viral infections of the central nervous system

120

3.62

13.40

1.0

735.32

295.66

ng/l

1.12

Other encephalitis

5.82

13.24

1.0

395.58

241.48

ng/l

0.91

Factors influencing health status and contact with health services

124

284

2.20

12.93

1.0

277.69

367.96

ng/l

1.73

223

Shoulder lesions

346

1345

1.56

12.87

1.0

292.30

352.66

ng/l

1.24

244

958

Sciatica+with lumbago

221

1192

1.71

12.69

1.0

252.69

363.77

ng/l

2.94

136

888

Abnormal findings on diagnostic imaging of central nervous system

3.92

12.55

1.1

1.0

258.72

291.26

ng/l

0.20

Viral infections of the central nervous system

131

3.39

12.45

1.0

728.14

296.28

ng/l

1.15

Cerebral cysts

4.25

12.45

1.0

1366.64

317.55

ng/l

0.49

Malignant neoplasm of digestive organs

1082

0.36

12.38

1.0

253.52

337.25

ng/l

2.59

738

Symptoms and signs involving speech and voice

156

838

1.87

12.24

1.0

286.60

330.28

ng/l

1.25

128

570

Dorsopathies

383

1284

1.52

12.14

1.0

297.76

362.83

ng/l

1.36

255

949

Behavioural syndromes associated with physiological disturbances and physical factors

357

1670

1.52

12.10

1.0

258.72

344.20

ng/l

3.21

260

1196

258

1407

1.62

11.96

1.0

292.60

314.40

ng/l

0.66

187

999

Dysphagia

129

656

1.98

11.95

1.0

273.24

334.64

ng/l

1.97

441

Sequelae of cerebrovascular disease

171

816

1.81

11.93

1.0

332.70

341.26

ng/l

0.11

123

551

Statin medication

230

761

1.70

11.89

1.0

273.07

380.81

ng/l

1.47

162

565

Other sleep disorders

226

2.72

11.85

1.0

311.60

335.52

ng/l

0.25

157

Viral encephalitis, not elsewhere classified/unspecified

5.97

11.85

1.0

345.86

273.43

ng/l

0.37

Encephalitis

5.19

11.77

1.0

395.58

227.59

ng/l

1.03

Lumbar disc prolapse

265

1266

1.61

11.73

1.0

271.59

363.00

ng/l

2.36

180

941

Fever of other and unknown origin

209

1098

1.70

11.69

1.0

289.81

367.43

ng/l

1.32

140

780

Other diseases of urinary system

400

1522

1.48

11.48

1.0

313.27

343.29

ng/l

0.44

290

1073

Other reaction to severe stress, and adjustment disorders

126

645

1.96

11.45

1.0

248.73

378.04

ng/l

1.58

475

Mental and behavioural disorders due to psychoactive substance use

246

1416

1.61

11.37

1.0

289.84

313.06

ng/l

0.71

183

1012

Secondary parkinsonism+Parkinsonism in other disease

4.65

11.22

1.0

225.50

332.29

ng/l

0.79

Degeneration of the brain due to alcohol

5.65

11.22

1.0

1.1

340.73

206.82

ng/l

1.13

Somnolence, stupor and coma

5.58

11.18

1.0

1.1

240.57

255.00

ng/l

0.10

245

1381

1.61

11.11

1.0

293.18

314.24

ng/l

0.61

180

979

Conductive and sensorineural hearing loss

365

1661

1.49

11.10

1.0

419.99

319.90

ng/l

0.47

250

1187

Pain in throat and chest

331

1309

1.52

11.02

1.0

375.05

337.64

ng/l

0.14

242

922

Mental and behavioural disorders due to alcohol

217

1274

1.64

10.83

1.0

299.42

313.74

ng/l

0.33

159

911

Non-invasive ventilation

102

440

2.08

10.70

1.1

1.0

260.86

440.03

ng/l

1.47

325

Other functional intestinal disorders

200

1113

1.67

10.67

1.0

292.80

368.17

ng/l

1.15

147

770

Other headache syndromes

156

876

1.78

10.62

1.0

521.91

328.07

ng/l

0.35

103

628

Alcohol use disorder, Swedish definition

233

1337

1.60

10.48

1.0

291.57

314.78

ng/l

0.68

169

954

Spinal stenosis

240

1142

1.60

10.43

1.0

284.30

373.67

ng/l

1.76

146

837

Other diseases of intestines

394

1545

1.45

10.39

1.0

293.59

341.97

ng/l

1.07

280

1102

Substance abuse

237

1405

1.59

10.35

1.0

286.31

314.23

ng/l

0.93

175

1006

Use of hypnotics and sedatives

429

1728

1.43

10.34

1.0

274.42

346.44

ng/l

2.36

322

1215

Secondary parkinsonism

4.47

10.30

1.0

230.18

296.14

ng/l

0.43

Unspecified fall

206

1242

1.64

10.28

1.0

463.86

323.42

ng/l

0.38

149

859

Symptoms and signs involving the urinary system

331

1704

1.48

10.22

1.0

314.67

336.34

ng/l

0.30

242

1188

Persistent delusional disorders

165

2.88

10.16

1.0

333.69

310.88

ng/l

0.19

106

Disorders of adult personality and behaviour

468

2.06

10.06

1.0

205.20

314.82

ng/l

8.78

349

Cervicalgia

449

2.08

10.02

1.0

276.31

347.50

ng/l

1.59

330

Sleep disorders

333

1632

1.48

10.01

1.0

257.93

343.82

ng/l

3.13

245

1167

Other external causes of accidental injury

302

991

1.53

9.97

1.0

301.66

326.64

ng/l

0.78

220

690

Persistent mood disorders

359

2.21

9.93

1.0

262.91

346.39

ng/l

2.49

264

Transient ischemic attack

245

1268

1.57

9.91

1.0

279.05

338.56

ng/l

3.38

170

862

Hypotension

413

2.12

9.81

1.0

269.43

325.47

ng/l

1.53

267

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

100

501

2.00

9.74

1.0

246.97

312.37

ng/l

2.42

368

Bleeding

358

1768

1.44

9.55

1.0

301.28

341.83

ng/l

0.92

237

1272

Sensorineural hearing loss

346

1626

1.45

9.32

1.0

428.28

321.41

ng/l

0.47

236

1156

Other soft tissue disorders, not elsewhere classified

336

1352

1.46

9.19

1.0

278.56

351.90

ng/l

1.65

235

961

Accidents

297

991

1.50

9.13

1.0

305.86

326.64

ng/l

0.59

218

690

Pain in limb

298

1351

1.48

8.94

1.0

265.39

351.90

ng/l

2.28

208

961

Diseases of oesophagus, stomach and duodenum

411

1771

1.39

8.68

1.0

306.77

336.81

ng/l

0.64

306

1252

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

816

0.33

8.66

1.0

417.94

346.72

ng/l

0.23

549

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

130

2.94

8.62

1.1

1.0

268.56

302.51

ng/l

0.51

Other CVD (FINNGEN)

270

2.17

8.59

1.1

1.0

272.98

379.45

ng/l

2.36

192

Suicide or other Intentional self-harm

485

1.95

8.49

1.0

247.86

312.83

ng/l

2.19

355

Mental and behavioural disorders due to alcohol, excluding acute intoxication

188

1181

1.59

8.38

1.0

301.95

303.63

ng/l

0.03

139

853

Vascular dementia (mixed)

9.60

8.31

1.0

1.1

334.78

252.50

ng/l

—

Transient global amnesia

123

2.95

8.22

1.0

327.70

230.37

ng/l

1.12

Personality disorders

465

1.94

8.12

1.0

203.73

316.44

ng/l

8.74

342

Nerve, nerve root and plexus disorders

413

1849

1.37

8.07

1.0

301.31

337.94

ng/l

0.88

305

1303

Persons encountering health services in other circumstances, wide

450

1710

1.36

8.00

1.0

267.05

355.62

ng/l

3.34

357

1170

External causes of morbidity and mortality

239

786

1.53

7.94

1.0

304.10

335.73

ng/l

0.87

171

546

Hypertension, essential

307

1213

1.44

7.75

1.0

406.92

323.42

ng/l

0.33

228

878

Heart failure and coronary heart disease

1012

0.51

7.72

1.0

252.35

339.49

ng/l

4.37

697

Traumatic subarachnoid haemorrhage

7.46

7.68

1.1

1.0

290.17

244.73

ng/l

0.47

Sleep apnoea

374

1760

1.38

7.67

1.0

379.12

325.32

ng/l

0.23

264

1258

Diseases of oral cavity, salivary glands and jaws

247

849

1.50

7.63

1.0

320.41

332.71

ng/l

0.24

160

593

Rotator cuff syndrome

270

1336

1.45

7.60

1.0

309.99

353.86

ng/l

0.69

194

951

Stroke, including SAH

277

1395

1.44

7.55

1.0

309.22

328.36

ng/l

0.48

184

973

Migraine without aura

230

2.31

7.53

1.0

261.97

323.89

ng/l

0.95

168

Inflammatory diseases of the central nervous system

176

2.52

7.48

1.1

1.0

340.97

286.10

ng/l

0.38

113

Alcohol use disorder, ICD-based

171

1091

1.57

7.36

1.0

302.94

304.25

ng/l

0.02

126

785

Dental operations

258

904

1.47

7.23

1.0

322.99

319.00

ng/l

0.07

168

628

Sleep apnoea, including avohilmo

387

1772

1.35

7.12

1.0

374.15

326.15

ng/l

0.21

272

1268

Influenza and pneumonia

384

1806

1.35

7.08

1.0

266.54

344.92

ng/l

2.92

276

1297

Hyperplasia of prostate

173

621

1.59

7.04

1.0

287.27

298.82

ng/l

0.24

127

424

Other CVD

490

1.84

6.99

1.0

266.89

332.05

ng/l

2.07

317

Degeneration of nervous system due to alcohol

3.76

6.95

1.0

340.73

252.53

ng/l

0.70

Any gastric operation

268

931

1.45

6.93

1.0

311.33

321.15

ng/l

0.21

175

741

GASTRO-related operations

268

931

1.45

6.93

1.0

311.33

321.15

ng/l

0.21

175

741

Spondylosis

225

1252

1.47

6.87

1.0

295.80

367.52

ng/l

1.29

137

928

Mixed and other personality disorders

125

2.74

6.85

1.0

209.30

272.00

ng/l

1.79

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.81

6.81

1.0

295.08

295.33

ng/l

0.00

Cervical disc disorders

152

965

1.58

6.73

1.0

298.07

364.68

ng/l

0.86

109

722

Insomnia

304

1598

1.39

6.72

1.0

259.63

344.84

ng/l

2.97

230

1141

Periodontitis

381

1904

1.34

6.66

1.0

299.26

337.76

ng/l

0.93

275

1353

Cardiodefibrillation

1148

0.50

6.60

1.0

250.17

330.45

ng/l

3.43

785

Status epilepticus

3.47

6.57

1.0

253.31

294.64

ng/l

0.38

Hypertensive diseases

300

1216

1.39

6.55

1.0

297.28

323.30

ng/l

0.48

222

879

Hypertension

300

1216

1.39

6.54

1.0

297.28

323.30

ng/l

0.48

222

879

Colorectal cancer

743

0.39

6.53

1.0

253.26

344.31

ng/l

2.71

494

Malignant neoplasm of bronchus and lung, including Hilmo

613

0.38

6.53

1.0

283.55

346.96

ng/l

0.97

404

Stroke, excluding SAH

259

1338

1.42

6.45

1.0

323.84

329.89

ng/l

0.10

172

928

Diabetes medication

383

1704

1.33

6.41

1.0

284.41

343.86

ng/l

1.67

275

1221

Restless leg syndrome

314

2.02

6.41

1.0

264.40

337.51

ng/l

2.79

209

All kidney diseases

364

1861

1.34

6.37

1.0

303.55

334.46

ng/l

0.68

274

1315

Other bacterial diseases

366

1842

1.34

6.35

1.0

282.61

340.66

ng/l

1.80

259

1324

Fracture of skull and facial bones

448

1.84

6.34

1.0

246.53

317.14

ng/l

2.85

315

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

268

2.10

6.34

1.0

235.35

301.44

ng/l

1.82

192

All pneumoniae

368

1843

1.34

6.34

1.0

270.09

343.00

ng/l

2.62

268

1319

Other lack of coordination

6.05

6.34

1.2

1.0

237.43

237.71

ng/l

—

Chronic periodontitis, including avohilmo

378

1907

1.33

6.32

1.0

299.79

337.56

ng/l

0.90

272

1356

Type 2 diabetes, wide definition

338

1600

1.35

6.32

1.0

284.67

350.35

ng/l

1.78

242

1150

Other bacterial diseases

377

1799

1.33

6.29

1.0

273.32

342.26

ng/l

2.36

263

1297

Hyperkinetic disorders, excluding more controls

7.79

6.12

1.0

1.1

198.77

193.22

ng/l

—

Retention of urine

153

813

1.55

6.09

1.0

354.29

334.59

ng/l

0.16

110

538

All influenza

100

588

1.71

6.04

1.0

244.62

326.97

ng/l

3.50

408

Colorectal adenocarcinoma

626

0.36

5.97

1.0

241.59

334.13

ng/l

3.01

414

Other and unspecified polyneuropathies, also in other diseases

539

1.73

5.94

1.1

1.0

256.47

319.13

ng/l

2.73

360

Injuries to the thorax

175

1181

1.48

5.89

1.0

282.87

326.88

ng/l

1.13

118

825

Endocrine, nutritional and metabolic diseases

262

947

1.40

5.85

1.0

291.95

339.71

ng/l

1.76

187

695

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

360

1859

1.32

5.84

1.0

271.79

341.91

ng/l

2.47

263

1330

Diseases of the ear and mastoid process

412

1585

1.31

5.81

1.0

387.83

315.25

ng/l

0.38

290

1145

Specific personality disorders

383

1.86

5.76

1.0

207.86

322.53

ng/l

6.76

281

Pneumonias (Asthma/COPD co-morbidities)

363

1851

1.32

5.75

1.0

270.44

342.57

ng/l

2.58

264

1325

Disturbances of smell and taste

4.90

5.74

1.1

1.0

332.80

255.31

ng/l

—

Acute and transient psychotic disorders

219

2.16

5.74

1.0

252.26

313.99

ng/l

1.02

150

Alcohol dependence

112

690

1.63

5.70

1.0

300.58

305.14

ng/l

0.06

487

Other and unspecified injuries of head

126

2.56

5.70

1.0

302.04

289.26

ng/l

0.08

Genitourinary diseases

208

717

1.46

5.69

1.0

285.75

306.36

ng/l

0.51

149

503

Pneumonia, organism unspecified

335

1775

1.32

5.55

1.0

275.55

346.68

ng/l

2.31

239

1270

Sequelae of injuries, of poisoning and of other consequences of external causes

550

1.70

5.55

1.0

276.45

311.89

ng/l

0.82

393

Later onset COPD

694

0.48

5.48

1.1

1.0

264.78

344.26

ng/l

1.65

431

COPD, hospital admissions

1247

0.60

5.43

1.0

307.68

336.86

ng/l

0.40

846

251

2.04

5.42

1.0

227.65

360.12

ng/l

6.21

165

Heart failure, strict

132

1416

0.66

5.42

1.0

245.35

337.36

ng/l

7.27

101

950

Dystonia

106

2.66

5.41

1.1

1.0

248.50

320.26

ng/l

1.47

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

365

1.84

5.40

1.0

274.94

309.61

ng/l

0.63

261

Caries of dentine, including avohilmo

304

1153

1.35

5.40

1.0

316.50

322.06

ng/l

0.12

212

803

All-cause Heart Failure

131

1404

0.66

5.34

1.0

246.38

337.76

ng/l

7.09

100

942

Implicit fungal Sepsis

3.20

5.32

1.1

1.0

256.20

358.44

ng/l

0.91

Injuries to the shoulder and upper arm

317

1934

1.32

5.32

1.0

412.75

319.00

ng/l

0.38

227

1374

Diseases of male genital organs

192

666

1.46

5.30

1.0

266.95

293.60

ng/l

0.80

146

460

Phobic anxiety disorders

125

2.48

5.25

1.0

227.54

320.03

ng/l

1.84

Biguanides

370

1738

1.30

5.24

1.0

281.35

346.12

ng/l

1.93

264

1250

Volume depletion

201

2.15

5.24

1.0

253.19

340.17

ng/l

1.05

127

Other problems related to primary support group, including family circumstances

116

2.52

5.23

1.0

253.79

308.14

ng/l

0.81

Symptoms and signs concerning food and fluid intake

201

2.15

5.22

1.0

281.31

330.37

ng/l

0.77

133

Cervicocranial syndrome

222

2.08

5.17

1.0

267.32

348.10

ng/l

1.18

165

COPD, early/later onset

1257

0.62

5.15

1.0

303.37

338.05

ng/l

0.53

853

Diseases of the myoneural junction and muscle

298

1.92

5.14

1.0

314.40

313.86

ng/l

0.00

199

COPD related to multimorbidity

1058

0.58

5.14

1.1

1.0

279.17

341.09

ng/l

1.25

706

Dental caries, including avohilmo

290

1103

1.35

5.12

1.0

322.75

324.53

ng/l

0.03

201

765

Soft tissue disorders

344

1353

1.31

5.06

1.0

288.89

351.73

ng/l

1.34

239

962

Vascular syndromes of brain in cerebrovascular disorders

3.30

5.03

1.1

1.0

277.00

218.31

ng/l

—

Diseases of the musculoskeletal system and connective tissue

163

550

1.49

5.02

1.0

280.19

326.23

ng/l

1.34

110

403

COPD, hospital admissions 3, with asthma pneumonia sepsis

695

0.49

4.99

1.1

1.0

276.71

332.02

ng/l

0.98

456

Hypertensive diseases (excluding secondary)

173

690

1.46

4.98

1.0

268.38

334.11

ng/l

2.34

126

527

Cystitis

294

1315

1.33

4.96

1.0

315.05

361.00

ng/l

0.61

213

916

Other (not insulin) diabetes medications

369

1701

1.29

4.92

1.0

281.52

345.22

ng/l

1.83

265

1220

Transport accidents

148

861

1.48

4.92

1.0

280.13

316.39

ng/l

0.83

111

595

COPD, hospital admissions 1, only main diagnosis

904

0.56

4.88

1.1

1.0

332.69

328.79

ng/l

0.03

605

Diarrhoea and gastroenteritis of presumed infectious origin

232

1537

1.36

4.85

1.0

295.77

334.06

ng/l

0.66

175

1064

Fracture of rib(s), sternum and thoracic spine

123

808

1.53

4.82

1.0

281.56

323.22

ng/l

0.75

561

Other diseases of hard tissues of teeth

227

849

1.39

4.82

1.0

321.38

332.71

ng/l

0.22

159

593

Explicit Sepsis

125

768

1.52

4.81

1.0

291.44

353.54

ng/l

1.54

474

Continuous positive airway pressure

371

1.73

4.80

1.0

335.46

368.97

ng/l

0.40

272

Hypersomnia

5.30

4.79

1.1

1.0

298.33

258.73

ng/l

—

Ischaemic Stroke, excluding all haemorrhages

233

1275

1.36

4.77

1.0

315.71

333.49

ng/l

0.34

157

875

Fracture at wrist and hand level

118

769

1.53

4.75

1.0

307.64

320.80

ng/l

0.17

542

Lung cancer and mesothelioma

542

0.44

4.71

1.0

283.55

366.19

ng/l

1.39

363

Bacterial infection, other or unspecified

213

1354

1.37

4.58

1.0

282.38

329.88

ng/l

2.00

152

937

Other and unspecified myopathies

200

2.06

4.53

1.0

303.35

310.04

ng/l

0.06

128

Migraine

135

740

1.48

4.50

1.0

253.62

329.95

ng/l

3.29

540

Oter anti-inflammatory and antirheumatic agents, non-steroids

297

1.66

4.47

1.0

260.50

334.86

ng/l

2.47

210

Disorders of lens

296

1417

1.31

4.46

1.0

304.80

348.93

ng/l

0.82

215

1030

Other chronic obstructive pulmonary disease

1184

0.64

4.43

1.0

303.37

334.85

ng/l

0.46

804

Non-small cell lung cancer, including Hilmo

460

0.39

4.42

1.0

320.64

341.44

ng/l

0.16

298

Disorders of eyelid, lacrimal system and orbit

315

1859

1.29

4.42

1.0

309.19

339.98

ng/l

0.61

219

1317

Polyneuropathies and other disorders of the peripheral nervous system

610

1.58

4.41

1.1

1.0

258.26

314.79

ng/l

2.48

413

Hypothyroidism, strict autoimmune, 3 medication purchases required

294

1526

1.30

4.41

1.0

293.49

349.78

ng/l

1.28

186

1100

Hypoglycaemia, other or unspecified

124

2.35

4.41

1.1

1.0

354.30

285.97

ng/l

0.59

Migraine without aura and triptan purchases

182

2.09

4.40

1.0

242.46

317.62

ng/l

1.73

130

Fungal Sepsis

2.84

4.39

1.1

1.0

256.20

365.36

ng/l

1.12

Heart failure,strict

127

1311

0.68

4.38

1.0

245.22

336.67

ng/l

6.90

900

COPD

1229

0.65

4.34

1.0

297.00

333.82

ng/l

0.62

835

Hard cardiovascular diseases

340

1588

1.28

4.33

1.0

296.84

342.45

ng/l

1.01

237

1166

Exposure to unspecified factor

345

1955

1.27

4.33

1.0

317.73

333.16

ng/l

0.25

272

1365

Bacterial infection, other or unspecified

228

1441

1.34

4.32

1.0

285.13

327.56

ng/l

1.78

161

1004

Fracture of neck

138

2.26

4.32

1.1

1.0

389.86

308.95

ng/l

0.35

Malignant neoplasm of colon, including Hilmo

593

0.45

4.29

1.0

278.20

334.32

ng/l

0.87

388

Fall involving bed

2.98

4.29

1.1

1.0

218.82

284.15

ng/l

0.75

Abnormalities of breathing

293

1309

1.30

4.28

1.0

380.69

337.64

ng/l

0.14

208

922

Malignant neoplasm of colon

448

0.38

4.22

1.0

251.00

336.31

ng/l

—

290

Hypothyroidism, drug reimbursement

109

2.21

4.20

1.0

338.25

337.51

ng/l

0.00

COPD, hospital admission 2, with asthma infections

821

0.57

4.18

1.1

1.0

290.69

330.32

ng/l

0.42

548

Cervicobrachial syndrome

509

1.62

4.17

1.0

225.44

400.00

ng/l

1.84

383

Gastro-oesophageal reflux disease

260

1719

1.31

4.16

1.0

299.80

339.50

ng/l

0.80

185

1218

Other chronic obstructive pulmonary disease, including avohilmo

124

1484

0.69

4.13

1.0

299.32

326.29

ng/l

0.45

1010

Pedestrian injured in transport accident

128

2.28

4.12

1.0

311.25

290.85

ng/l

0.10

Persons encountering health services for other counselling and medical advice, not elsewhere classified

393

1710

1.25

4.12

1.0

265.86

355.62

ng/l

3.37

308

1170

Other disorders of fluid, electrolyte and acid-base balance

125

813

1.47

4.10

1.0

526.60

353.08

ng/l

0.26

542

Somatoform disorder

301

1.80

4.07

1.0

264.16

345.74

ng/l

2.55

206

Schizophrenia

323

1.77

4.06

1.0

229.02

325.04

ng/l

4.31

235

Disturbance of activity and attention

4.25

4.04

1.0

198.77

214.86

ng/l

0.20

Injuries to the abdomen, lower back, lumbar spine and pelvis

135

930

1.44

4.02

1.0

308.81

328.70

ng/l

0.26

645

Injury, poisoning and certain other consequences of external causes

174

623

1.40

4.02

1.0

316.66

340.75

ng/l

0.46

120

447

Emotionally unstable personality disorder

136

2.21

4.01

1.0

188.00

292.33

ng/l

2.91

Pain in joint

200

940

1.36

4.01

1.0

285.68

339.13

ng/l

2.30

152

692

Diplopia

310

1.78

4.00

1.0

254.89

320.28

ng/l

1.81

212

Systemic atrophies primarily affecting the central nervous system

2.49

3.97

1.1

1.0

271.75

304.42

ng/l

0.31

Migraine with aura

355

1.72

3.97

1.0

213.55

358.43

ng/l

6.69

250

Cramp and spasm

2.55

3.97

1.1

1.0

317.31

270.64

ng/l

0.19

Certain infectious and parasitic diseases

272

1046

1.30

3.95

1.0

297.55

358.01

ng/l

0.94

187

751

Symptoms and signs involving the digestive system and abdomen

354

1409

1.26

3.94

1.0

312.67

320.31

ng/l

0.18

250

1005

Hypothyreosis and Thyroxine purchase for inclusion criteria

320

1657

1.27

3.93

1.0

290.46

349.90

ng/l

1.53

209

1187

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

100

1183

0.67

3.93

1.0

360.00

351.75

ng/l

0.04

849

Pain (limb, back, neck, head abdominally)

251

956

1.32

3.92

1.0

296.87

339.69

ng/l

1.49

171

697

Disorders of ocular muscles, binocular movement, accommodation and refraction

145

1022

1.41

3.87

1.0

316.47

353.29

ng/l

0.38

733

Other/unspecified dorsalgia

124

851

1.45

3.84

1.0

262.59

374.24

ng/l

1.82

630

Disorders of choroid and retina

316

1779

1.26

3.83

1.0

334.38

337.86

ng/l

0.04

229

1250

Injuries to the elbow and forearm

239

1613

1.30

3.82

1.0

324.40

338.35

ng/l

0.21

166

1148

Diseases of pulp and periapical tissues and dental caries

254

996

1.31

3.81

1.0

330.78

324.07

ng/l

0.12

170

686

Special screening examination for infectious and parasitic diseases

186

1.86

3.78

1.0

279.21

304.86

ng/l

0.37

159

Visual disturbances and blindness

183

1358

1.35

3.77

1.0

339.50

340.06

ng/l

0.00

130

945

Pain, not elsewhere classified

540

1.56

3.73

1.0

253.93

348.13

ng/l

4.26

389

Senile cataract

279

1336

1.28

3.71

1.0

312.34

356.50

ng/l

0.75

199

966

Injuries to the wrist and hand

345

1920

1.25

3.70

1.0

288.20

337.65

ng/l

1.33

267

1351

Used for control exclusion in common control thyroid runs

363

1473

1.25

3.70

1.0

292.86

345.11

ng/l

1.14

247

1064

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

344

1661

1.25

3.69

1.0

282.88

345.76

ng/l

1.69

248

1191

Visual disturbances

169

1245

1.36

3.68

1.0

331.57

342.07

ng/l

0.08

121

870

Postmenopausal osteoporosis with pathological fracture

135

2.16

3.67

1.0

281.18

346.66

ng/l

0.91

314

1510

1.26

3.65

1.0

269.52

358.30

ng/l

2.70

227

1077

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

314

1510

1.26

3.65

1.0

269.52

358.30

ng/l

2.70

227

1077

Diabetes mellitus

353

1661

1.24

3.63

1.0

278.43

345.77

ng/l

1.96

253

1191

Hernia

335

1803

1.25

3.61

1.0

283.88

340.97

ng/l

1.59

230

1299

Hyperkinetic disorders

3.75

3.60

1.0

198.77

205.94

ng/l

0.08

Hypothyroidism, strict autoimmune

259

1327

1.28

3.59

1.0

297.19

353.92

ng/l

1.05

165

947

Other diseases of pleura

1218

0.67

3.57

1.1

1.0

328.41

329.84

ng/l

0.01

826

Diabetes, varying definitions

351

1663

1.24

3.51

1.0

279.35

345.54

ng/l

1.91

252

1192

Colon adenocarcinoma

350

0.37

3.45

1.0

223.13

335.63

ng/l

—

217

Fall on same level involving ice and snow

203

1553

1.31

3.44

1.0

490.46

316.04

ng/l

0.44

136

1098

Diverticular disease of intestine

289

1466

1.26

3.42

1.0

310.23

348.91

ng/l

0.69

195

1043

Primary hyperparathyroidism

274

1.76

3.41

1.1

1.0

266.00

343.04

ng/l

1.73

181

Any event in cancer register

226

1711

0.78

3.40

1.0

427.46

321.17

ng/l

0.30

164

1223

Hypo-osmolality and hyponatraemia

455

1.58

3.40

1.0

211.96

350.59

ng/l

13.57

304

Diabetes, insulin treatment (Kela reimbursement)

364

1792

1.23

3.39

1.0

281.19

343.26

ng/l

1.83

263

1280

Type 2 diabetes

350

1659

1.23

3.39

1.0

271.27

345.93

ng/l

2.36

249

1190

Dipeptidyl peptidase 4 (DPP-4) inhibitors

230

1431

1.29

3.38

1.0

284.35

361.33

ng/l

1.77

156

999

Other specified/unspecified disorders of bone/cartilage

2.86

3.36

1.0

291.50

226.36

ng/l

—

Renal tubulo-interstitial diseases

306

1834

1.24

3.32

1.0

305.38

337.47

ng/l

0.69

227

1282

Meningitis

2.31

3.26

1.1

1.0

229.00

278.48

ng/l

0.38

Unspecified urinary incontinence

205

1.86

3.25

1.0

287.00

324.98

ng/l

0.43

131

Gingivitis and periodontal diseases

362

1525

1.23

3.25

1.0

303.06

344.54

ng/l

0.83

251

1082

Later onset COPD, excluding more controls

543

0.57

3.23

1.1

1.0

246.47

371.39

ng/l

3.71

351

Hypothyroidism, other/unspecified

302

1599

1.24

3.22

1.0

291.01

351.26

ng/l

1.49

197

1148

Voice disturbances

651

1.46

3.18

1.0

302.59

340.57

ng/l

0.77

445

Oedema, not elsewhere classified

104

717

1.43

3.14

1.0

268.71

350.64

ng/l

3.39

498

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

3.13

0.0

1.0

—

324.64

—

Fissure and fistula of anal and rectal regions

621

1.47

3.12

1.0

281.07

332.94

ng/l

1.39

439

Anomalies of pupillary function

3.70

3.09

1.0

225.33

266.68

ng/l

—

Eating disorders

2.28

3.08

1.0

269.64

284.98

ng/l

0.09

Fracture of forearm

190

1340

1.30

3.08

1.0

333.33

349.62

ng/l

0.20

133

950

Disorders of the thyroid gland

322

1709

1.23

3.08

1.0

291.41

345.13

ng/l

1.36

213

1234

Cardiovascular diseases (excluding rheumatic etc)

162

694

1.34

3.08

1.0

276.14

333.45

ng/l

1.92

112

529

Nontraumatic intracranial haemmorrhage

486

1.53

3.06

1.0

337.33

333.84

ng/l

0.03

326

Amyloidosis, other/unspecified

2.93

3.04

1.1

1.0

632.23

289.07

ng/l

1.61

Other general symptoms and signs

2.66

3.00

1.0

189.50

292.31

ng/l

—

Other disorders of glucose regulation and pancreatic internal secretion

161

1.93

2.99

1.1

1.0

345.14

297.68

ng/l

0.40

105

Peripheral arterial reconstruction

463

0.50

2.97

1.0

309.62

314.29

ng/l

0.03

295

Psoriasis

745

0.60

2.96

1.0

337.43

326.65

ng/l

0.07

535

Bacterial meningitis

2.56

2.96

1.1

1.0

227.10

286.47

ng/l

—

Acute tubulo-interstitial nephritis

219

1491

1.27

2.93

1.1

1.0

320.35

352.53

ng/l

0.45

161

1019

Oxycodone

1139

0.70

2.89

1.0

275.14

337.26

ng/l

0.97

783

Certain infectious and parasitic diseases

333

1370

1.22

2.85

1.0

310.01

344.32

ng/l

0.46

237

972

Symptoms and signs involving the circulatory and respiratory systems

319

1309

1.22

2.82

1.0

276.86

337.64

ng/l

3.36

232

922

Insulin, intermediate and long-acting

195

1485

1.28

2.82

1.0

302.53

321.97

ng/l

0.35

139

1032

Exclusions for E4_PCOS_CONSORTIUM

210

1033

1.27

2.80

1.0

495.26

324.28

ng/l

0.52

160

738

Viral and other specified intestinal infections

262

1.68

2.78

1.1

1.0

270.42

307.64

ng/l

0.55

173

Migraine with aura and triptan purchases

187

1.82

2.77

1.0

221.30

312.45

ng/l

3.33

132

Cardiomyopathy

555

0.56

2.77

1.0

297.00

329.73

ng/l

0.24

373

Disorders of other endocrine glands

135

993

1.34

2.76

1.0

259.37

325.16

ng/l

3.18

101

684

Acute alcohol intoxication

613

1.44

2.76

1.0

280.23

308.31

ng/l

0.45

430

Injury of muscle and tendon at shoulder and upper arm level

142

1071

1.33

2.76

1.0

321.29

319.10

ng/l

0.03

103

756

Complications of other internal prosthetic devices, implants and grafts

2.21

2.74

1.1

1.0

599.25

329.41

ng/l

—

Diseases of the eye and adnexa

248

994

1.25

2.73

1.0

297.06

340.50

ng/l

0.58

186

749

Other intracranial haemorrhages

2.44

2.71

1.1

1.0

177.80

308.46

ng/l

—

Diseases of tongue

125

2.01

2.70

1.0

284.93

361.24

ng/l

0.94

Other disorders of nervous system

132

1.98

2.70

1.1

1.0

371.53

324.74

ng/l

0.17

Exclusions for E4_PCOS_BROAD

341

1.59

2.68

1.0

238.18

320.95

ng/l

2.84

235

Abnormal findings in secretions and smears from cervix uteri vagina vulva

752

0.67

2.68

1.0

319.25

371.87

ng/l

0.42

558

Solid cancers, helper endpoint

226

1661

0.80

2.68

1.0

433.01

317.52

ng/l

0.32

160

1192

Gout, strict definition

547

0.56

2.65

1.0

259.28

310.31

ng/l

0.86

362

3.17

2.65

1.0

246.83

273.15

ng/l

—

Irritable bowel syndrome

619

1.42

2.63

1.0

306.54

329.14

ng/l

0.38

430

Superficial injury of abdomen, lower back and pelvis

304

1.62

2.63

1.0

230.56

315.69

ng/l

2.82

208

Disorders of parathyroid gland

506

1.47

2.62

1.0

263.82

346.11

ng/l

2.86

340

Unstable angina pectoris

975

0.71

2.61

1.0

258.90

341.14

ng/l

3.88

676

Endovascular or surgical operations to intracerebral aneurysms

155

1.88

2.61

1.1

1.0

390.43

323.11

ng/l

0.34

Other disorders of penis

206

1.75

2.60

1.1

1.0

368.44

296.06

ng/l

0.68

139

Polyuria

596

1.43

2.60

1.0

323.20

326.80

ng/l

0.05

398

Disorders of vestibular function (Vertigo)

173

1330

1.28

2.59

1.0

516.51

320.22

ng/l

0.42

117

932

Other fall from one level to another

497

1.47

2.59

1.0

320.77

311.95

ng/l

0.06

343

Basal cell carcinoma, including avohilmo

131

1193

0.76

2.59

1.1

1.0

300.60

338.82

ng/l

1.02

820

Inguinal hernia

206

1094

1.26

2.57

1.0

276.20

317.36

ng/l

1.43

137

774

Atherosclerosis, excluding cerebral and coronary sclerosis

1049

0.72

2.57

1.0

314.92

340.36

ng/l

0.41

698

Paracetamol or NSAID medication

130

1.71

2.56

1.0

228.58

386.80

ng/l

4.98

Redundant prepuce, phimosis and paraphimosis

413

1.51

2.56

1.0

252.68

288.04

ng/l

0.83

283

Cardiovascular diseases

139

561

1.33

2.55

1.0

277.33

321.30

ng/l

1.16

435

Carcinoma in situ of skin

213

0.37

2.52

1.1

1.0

368.00

326.21

ng/l

—

133

Injuries to the hip and thigh

164

1157

1.29

2.51

1.0

325.78

331.61

ng/l

0.09

104

791

Other disorders of eye and adnexa

285

1.62

2.50

1.0

274.29

330.64

ng/l

0.75

188

Type 2 diabetes, definitions combined

337

1656

1.20

2.50

1.0

274.01

346.38

ng/l

2.18

235

1188

Gastrointestinal diseases

185

725

1.28

2.50

1.0

312.29

333.58

ng/l

0.38

123

512

Fracture of lumbar spine and pelvis

534

1.44

2.49

1.0

355.16

333.08

ng/l

0.16

352

Diabetic retinopathy, excluding more controls

332

1.44

2.46

1.0

257.28

304.27

ng/l

1.07

234

Injuries to the neck

455

1.48

2.44

1.0

307.15

308.09

ng/l

0.01

327

Type 2 diabetes, strict (exclude DM1)

337

1661

1.19

2.43

1.0

274.69

347.25

ng/l

2.20

236

1192

Hepatocellular carcinoma

0.00

2.43

0.0

1.0

—

325.29

—

Calcific aortic valvular stenosis, operated

813

0.67

2.42

1.0

328.11

330.04

ng/l

0.02

521

Calcific aortic valvular stenosis

813

0.67

2.42

1.0

328.11

330.04

ng/l

0.02

521

Acute alcohol intoxication, ICD10

464

1.47

2.42

1.0

260.09

302.20

ng/l

0.81

331

Cardiomyopathy (excluding other)

403

0.52

2.41

1.0

253.31

309.16

ng/l

0.50

269

Substance use, excluding alcohol

375

1.52

2.41

1.1

1.0

227.42

311.95

ng/l

4.04

272

Operations 2 for CAVS

812

0.67

2.41

1.0

328.11

329.91

ng/l

0.02

520

Calcific aortic valvular stenosis, diagnosis (helper)

812

0.67

2.41

1.0

328.11

329.91

ng/l

0.02

520

Finngen Rheumatological endpoints

319

1517

1.20

2.40

1.0

320.65

334.33

ng/l

0.16

229

1090

Intestinal infectious diseases

390

1896

1.18

2.39

1.0

298.65

337.60

ng/l

0.95

295

1330

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

329

1801

1.19

2.38

1.0

293.78

335.73

ng/l

1.01

244

1287

Colonic or urogenital fistula

683

1.38

2.37

1.0

293.39

330.77

ng/l

0.84

478

Fracture of femur

618

1.38

2.37

1.0

323.47

338.14

ng/l

0.20

407

Other specific joint derangements/joint disorders

227

1190

1.23

2.37

1.0

289.14

310.98

ng/l

0.74

167

857

Excessive earwax

196

1537

1.25

2.36

1.0

307.60

324.23

ng/l

0.32

121

1070

Missing teeth due to accident, extraction or parodontitis

230

1771

1.22

2.36

1.1

1.0

491.12

323.71

ng/l

0.47

148

1265

Abdominal and pelvic pain

334

1409

1.19

2.35

1.0

305.10

320.31

ng/l

0.43

241

1005

Neuromuscular dysfunction of bladder

198

1.72

2.35

1.1

1.0

245.42

302.45

ng/l

0.90

132

Calcific aortic valvular stenosis, including rheumatic fever

817

0.67

2.33

1.0

329.72

330.03

ng/l

0.00

521

In situ neoplasms

1009

0.70

2.33

1.0

339.14

331.65

ng/l

0.09

680

Aortic aneurysm

685

0.64

2.32

1.0

304.24

334.38

ng/l

0.46

450

Non-rheumatic valve diseases

128

1203

0.77

2.32

1.0

320.93

331.63

ng/l

0.19

839

Malignant neoplasm of pancreas, including Hilmo

248

0.40

2.31

1.0

215.40

338.53

ng/l

—

156

Impingement syndrome of shoulder

721

1.36

2.31

1.0

296.54

378.75

ng/l

0.80

514

Pain in thoracic spine

300

1.57

2.29

1.0

246.39

347.46

ng/l

2.23

226

Hyperparathyroidism

440

1.46

2.29

1.0

272.76

346.11

ng/l

2.05

291

Abnormal findings on diagnostic imaging of other body structures

368

0.51

2.27

1.0

258.25

343.10

ng/l

1.49

248

Anorexia (incl.atypical)

2.56

2.26

1.1

1.0

186.60

251.85

ng/l

—

Disorders of brain, other and unspecified

3.94

2.26

1.0

3884.00

252.00

ng/l

—

Other ill-defined and unspecified causes of mortality

178

1.75

2.26

1.0

371.69

309.85

ng/l

0.24

110

Allergic rhinitis

515

1.42

2.25

1.0

294.39

325.07

ng/l

0.53

365

Malignant neoplasm of small intestine

0.00

2.25

0.0

1.0

—

272.94

—

Chronic apical periodontitis

369

1791

1.17

2.25

1.0

395.59

320.48

ng/l

0.34

260

1266

Non-ischemic cardiomyopathy

808

0.71

2.25

1.0

268.91

357.41

ng/l

3.11

544

Other disorders starting during childhood or adolescence

4.58

2.25

1.0

218.75

280.88

ng/l

—

Primary gonarthrosis, bilateral

138

1514

0.78

2.24

1.0

289.12

355.57

ng/l

1.49

1061

Disorders of synovium and tendon

175

1224

1.25

2.22

1.0

339.60

356.10

ng/l

0.18

134

882

Cardiomyopathies, Primary/intrinsic

391

0.54

2.22

1.0

253.31

308.48

ng/l

0.49

262

Nausea and vomiting

586

1.39

2.22

1.0

322.21

339.02

ng/l

0.21

393

Rheumatism, unspecified

327

1.53

2.21

1.0

323.52

359.67

ng/l

0.34

225

Other heart diseases

137

690

1.30

2.20

1.0

301.25

333.99

ng/l

0.72

101

527

Malignant neoplasm of prostate, including Hilmo

700

0.73

2.19

1.0

274.50

305.57

ng/l

0.67

487

Retinal detachments and breaks

134

1041

1.29

2.18

1.0

382.88

326.26

ng/l

0.56

105

708

Basal cell carcinoma

129

1151

0.77

2.18

1.1

1.0

301.97

338.80

ng/l

0.91

785

Osteoporosis

648

1.36

2.17

1.0

300.40

338.83

ng/l

0.77

434

Other disorders of lacrimal gland

120

919

1.31

2.17

1.0

320.08

366.38

ng/l

0.45

640

Pneumonitis due to solids and liquids

188

1.71

2.16

1.0

320.95

297.82

ng/l

0.18

119

Gout, unspecified

613

0.63

2.16

1.0

287.24

311.27

ng/l

0.29

409

Strabismus

541

1.40

2.16

1.0

289.80

324.61

ng/l

0.46

383

Other gastritis (incl. Duodenitis)

602

1.38

2.15

1.0

342.87

328.14

ng/l

0.20

414

Pleural effusion

438

0.57

2.15

1.0

302.69

324.94

ng/l

0.22

283

Valvular operations

463

0.58

2.14

1.0

350.81

331.90

ng/l

0.16

309

Valvular heart disease excluding rheumatic fever

130

1205

0.78

2.14

1.0

317.88

331.68

ng/l

0.26

840

Psoriatic arthropathies

239

0.42

2.14

1.0

222.00

331.75

ng/l

—

174

Type of accident

663

1.36

2.13

1.0

352.29

322.95

ng/l

0.26

461

Intracerebral haemorrhage

298

1.55

2.13

1.0

389.48

337.23

ng/l

0.41

192

Diseases of inner ear

197

1553

1.23

2.12

1.0

525.04

316.26

ng/l

0.55

134

1095

Viral and other specified intestinal infections

365

1.48

2.12

1.1

1.0

271.41

307.79

ng/l

0.67

246

Malignant neoplasm

233

1663

0.83

2.11

1.0

428.68

317.38

ng/l

0.33

169

1193

Other cataract

174

1056

1.25

2.11

1.0

329.67

337.43

ng/l

0.13

123

750

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.62

2.11

1.0

213.79

254.23

ng/l

—

COPD (mode)

806

0.72

2.10

1.0

305.82

351.28

ng/l

0.61

543

Other respiratory diseases principally affecting the interstitium

497

0.60

2.09

1.0

271.74

323.84

ng/l

0.55

326

Benign neoplasm of brain and other parts of central nervous system

138

1.82

2.09

1.1

1.0

312.69

303.26

ng/l

0.05

Tramadol

277

1428

1.19

2.09

1.0

271.97

331.47

ng/l

3.29

206

1005

Fall on and from stairs and steps

632

1.36

2.07

1.0

295.54

325.09

ng/l

0.68

444

Other postsurgical states

154

1.76

2.04

1.0

148.00

309.11

ng/l

—

Alcohol abuse, main dg

350

1.49

2.03

1.0

253.32

302.79

ng/l

0.96

252

Asthma (mode)

261

1168

1.20

2.02

1.0

284.87

337.97

ng/l

2.51

183

822

Benign paroxysmal vertigo

102

773

1.32

2.02

1.1

1.0

669.30

337.85

ng/l

0.42

535

Asthma and allergy, excluding more controls

182

1.68

2.01

1.1

1.0

278.96

348.42

ng/l

1.00

124

Autoimmune diseases

362

1581

1.17

2.01

1.0

306.68

339.72

ng/l

0.63

246

1144

Weight loss

239

1.60

2.01

1.1

1.0

284.88

315.64

ng/l

0.38

156

Subjective visual disturbances

602

1.36

2.00

1.0

387.32

328.13

ng/l

0.34

426

Type 2 diabetes, definitions combined, including avohilmo

329

1637

1.17

2.00

1.0

266.79

348.40

ng/l

2.67

233

1173

Mixed conductive and sensorineural hearing loss

319

1.51

2.00

1.0

339.41

321.10

ng/l

0.19

221

Peripheral artery disease

107

1108

0.77

1.99

1.0

310.87

336.43

ng/l

0.45

743

Bronchitis, not specified as acute or chronic

193

1.66

1.99

1.1

1.0

366.29

311.37

ng/l

0.30

123

Insulin medication

202

1398

1.22

1.98

1.0

301.94

327.22

ng/l

0.51

144

980

Supplementary factors related to causes of morbidity and mortality classified elsewhere

715

1.33

1.98

1.0

343.73

320.69

ng/l

0.22

500

Fibroblastic disorders

604

1.36

1.97

1.0

290.97

343.69

ng/l

1.42

423

Malignant neoplasm of prostate

677

0.74

1.96

1.0

275.59

308.05

ng/l

0.70

472

Malignant neoplasm of skin

152

1297

0.80

1.95

1.1

1.0

287.05

332.55

ng/l

1.45

102

902

Persons encountering health services in other circumstances

121

939

1.28

1.94

1.0

283.86

337.69

ng/l

2.09

632

Ocular pain

149

1.75

1.94

1.1

1.0

248.76

309.64

ng/l

0.88

Tonsillectomy and adenotomy

672

0.72

1.93

1.0

253.08

297.65

ng/l

1.43

504

Any reimbursement code in KELA

157

627

1.26

1.91

1.0

262.96

339.29

ng/l

2.83

111

468

Malignant melanoma

447

0.60

1.91

1.0

275.63

332.59

ng/l

0.52

294

Periapical abscess

152

1223

1.24

1.90

1.0

297.94

337.34

ng/l

0.48

117

876

Budesonide

315

1.50

1.89

1.0

319.20

322.57

ng/l

0.03

224

Use of pramipexole

574

1.36

1.89

1.0

304.98

336.46

ng/l

0.50

396

Psoriasis vulgaris

471

0.61

1.89

1.0

294.71

316.00

ng/l

0.15

340

Malignant melanoma, including Hilmo

532

0.64

1.89

1.0

266.48

339.24

ng/l

0.91

357

Cough

139

1047

1.26

1.89

1.0

322.95

348.98

ng/l

0.49

109

729

Presbyopia

143

1.76

1.89

1.0

351.61

296.72

ng/l

0.26

Secondary malignant neoplasm of other and unspecified sites

0.00

1.89

0.0

1.0

—

333.78

—

Carbimazole or st.post thyroidectomy, condition for graves disease

469

0.62

1.86

1.0

281.48

335.30

ng/l

0.74

328

751

0.72

1.86

1.1

1.0

299.23

348.52

ng/l

1.00

485

Colectomy operation

456

0.61

1.85

1.0

303.72

323.10

ng/l

0.16

310

Asthma and allergy

187

1.64

1.84

1.1

1.0

278.96

346.60

ng/l

0.97

128

Complications of surgical and medical care, not elsewhere classified

331

1957

1.16

1.84

1.0

421.87

316.24

ng/l

0.45

231

1398

Asthma

263

1165

1.18

1.83

1.0

281.82

338.10

ng/l

2.81

187

820

Bacterial, viral and other infectious agents

152

1.72

1.83

1.0

282.00

259.79

ng/l

0.15

105

Drug-induced neutropenia

181

0.44

1.81

1.0

414.00

318.97

ng/l

—

116

Benign neoplasm of colon, rectum, anus and anal canal

244

1794

1.18

1.79

1.0

305.03

345.40

ng/l

0.88

175

1252

Vasomotor and allergic rhinitis

102

773

1.30

1.79

1.0

279.33

309.85

ng/l

0.72

560

Benign neoplasm: Cerebral meninges

231

1.56

1.78

1.0

313.67

329.19

ng/l

0.11

145

Pain associated with micturition

271

1.52

1.78

1.0

249.19

321.81

ng/l

1.98

179

malignant neoplasm of male genital organs

691

0.76

1.77

1.0

275.31

306.57

ng/l

0.69

480

Gonarthrosis, primary, with knee surgery

167

1617

0.82

1.77

1.0

338.17

349.90

ng/l

0.15

100

1137

Reimbursement for rheumatic diseases

129

1602

0.80

1.77

1.0

349.95

335.94

ng/l

0.16

1143

Maternal care related to the fetus and amniotic cavity and possible delivery problems

504

0.72

1.76

1.0

283.32

389.12

ng/l

0.81

391

Abnormal weight loss

224

1.57

1.76

1.1

1.0

271.84

308.74

ng/l

0.50

145

Coronary artery bypass grafting

645

0.73

1.75

1.0

280.59

343.64

ng/l

1.79

437

Hypertrophic disorders of skin

2.03

1.75

1.0

167.50

296.69

ng/l

—

Panic disorder

162

1.67

1.74

1.0

201.68

319.40

ng/l

4.69

110

Osteoporosis with pathological fracture (FG)

178

1.64

1.72

1.0

281.18

372.84

ng/l

1.51

116

Crowding of teeth, including avohilmo

0.00

1.72

0.0

1.0

—

244.93

—

Abnormal blood-pressure reading, without diagnosis

103

1.85

1.71

1.1

1.0

234.82

312.28

ng/l

0.86

Hemiplegia

1.92

1.70

1.1

1.0

259.33

295.04

ng/l

0.48

Pneumocystosis

0.00

1.69

0.0

1.0

—

267.50

—

Malignant melanoma of skin, including Hilmo

444

0.63

1.69

1.0

254.58

334.00

ng/l

0.81

290

Gout, idiopatic and unspecified

741

0.71

1.68

1.0

283.00

319.13

ng/l

0.69

504

Heart failure and antihypertensive medication

510

0.72

1.68

1.0

253.86

343.29

ng/l

2.61

390

Autoimmune diseases excluding thyroid diseases, strict definition

325

1544

1.15

1.67

1.0

311.58

341.67

ng/l

0.54

242

1116

Hypertensive Heart Disease

599

0.72

1.66

1.0

294.17

354.29

ng/l

1.16

400

Type 1 diabetes

518

1.35

1.66

1.0

315.85

321.27

ng/l

0.06

365

Superficial injury of lower leg

528

1.35

1.65

1.0

288.76

337.34

ng/l

0.88

374

Asthma, excluding more controls

253

1123

1.18

1.65

1.0

276.04

340.41

ng/l

3.66

181

793

Ill-defined and unknown causes of mortality

212

1.56

1.65

1.0

350.73

319.64

ng/l

0.13

132

Actinic keratosis

1063

0.77

1.64

1.0

321.10

346.22

ng/l

0.45

693

Other disorders of the musculoskeletal system and connective tissue

376

1.41

1.64

1.1

1.0

263.41

321.33

ng/l

1.08

260

Persons encountering health services for specific procedures, not carried out

150

1.67

1.63

1.0

237.59

330.08

ng/l

1.66

Abnormal findings on diagnostic imaging of lung

124

1472

0.81

1.62

1.0

289.50

331.25

ng/l

1.37

995

Other malignant neoplasms of skin (=non-melanoma skin cancer)

141

1185

0.81

1.62

1.1

1.0

297.33

336.63

ng/l

1.12

812

Osteopathies and chondropathies

189

1475

1.19

1.62

1.0

305.00

341.03

ng/l

0.57

130

1038

malignant neoplasm of female genital organs

412

0.63

1.61

1.1

1.0

283.38

376.39

ng/l

1.58

276

Intestinal infectious diseases

294

1935

1.15

1.60

1.0

299.38

336.30

ng/l

0.84

226

1356

Heart failure and bmi 25plus

653

0.75

1.60

1.0

233.26

310.58

ng/l

4.94

437

Disorders of skin appendages

133

1078

1.23

1.59

1.0

291.70

347.07

ng/l

0.70

774

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

153

1259

0.82

1.59

1.1

1.0

298.61

334.62

ng/l

1.07

100

870

L02BG Aromatase inhibitors

869

0.75

1.59

1.0

333.52

383.31

ng/l

0.44

611

Renal failure

109

1208

0.80

1.59

1.0

305.19

341.36

ng/l

0.74

811

Bacterial, viral and other infectious agents

159

1.64

1.58

1.0

282.00

260.44

ng/l

0.14

109

1.90

1.58

1.0

324.13

342.36

ng/l

—

Paralytic strabismus

167

1.62

1.58

1.0

196.21

320.72

ng/l

2.40

104

Atrial fibrillation and flutter with reimbursement

563

0.74

1.57

1.0

342.33

354.48

ng/l

0.12

427

Viral pneumonia

296

1.46

1.57

1.0

234.20

328.87

ng/l

3.07

206

Malignant neoplasm of breast, HER2-negative

808

0.78

1.57

1.0

660.70

342.74

ng/l

0.44

583

Malignant neoplasm, wide definition for exclusion

244

1667

0.86

1.57

1.0

426.02

316.74

ng/l

0.34

178

1197

Use of disulfiram, acamprosate or naltrexone

199

1.56

1.0

242.13

289.85

ng/l

0.89

142

Lesion of sciatic nerve

1.86

1.56

1.0

250.56

299.62

ng/l

—

Psoriatic and enteropathic arthropathies

273

0.55

1.55

1.0

254.25

321.71

ng/l

—

200

Benign neoplasm of meninges

256

1.49

1.55

1.0

310.89

338.15

ng/l

0.21

164

Papulosquamous disorders

1115

0.78

1.55

1.0

322.52

354.47

ng/l

0.31

794

Insulin, combination of fast acting with intermediate-acting or long-acting

202

1563

1.18

1.54

1.0

301.94

320.92

ng/l

0.35

144

1083

Propionic acid derivatives

299

1.33

1.54

1.0

277.41

333.33

ng/l

0.80

212

Autoimmune diseases excluding thyroid diseases

331

1580

1.14

1.54

1.0

308.98

339.72

ng/l

0.57

246

1144

Diabetic neuropathy

239

1.50

1.53

1.1

1.0

270.08

276.13

ng/l

0.07

166

Other enthesopathies

781

1.27

1.53

1.0

301.51

370.51

ng/l

0.72

563

Cardiac arrhythmias

172

930

1.20

1.53

1.0

305.74

363.77

ng/l

0.73

125

695

Caries of dentine

488

1.34

1.51

1.0

827.85

331.52

ng/l

0.52

355

Malignant neoplasm of breast, HER-positive

771

0.77

1.50

1.0

321.74

346.25

ng/l

0.36

552

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.00

1.50

0.0

1.0

—

323.07

—

Malignant neoplasm of bladder, including Hilmo

355

0.61

1.50

1.0

374.21

324.90

ng/l

0.56

224

Other interstitial pulmonary diseases

418

0.64

1.49

1.0

289.19

324.84

ng/l

0.28

275

Other and unspecified follicular disorders

2.01

1.48

1.0

310.25

268.73

ng/l

—

Hypertrophic scar

2.01

1.48

1.0

130.29

281.02

ng/l

—

Vocal cord dysfunction

246

1.46

1.48

1.0

309.50

521.95

ng/l

0.80

183

Postpartum haemorrhage

259

0.58

1.48

1.0

452.67

294.46

ng/l

0.77

203

Tongue abnormality

139

1.66

1.48

1.0

291.15

315.08

ng/l

0.20

Disorders of sclera, cornea, iris and ciliary body

170

1426

1.19

1.48

1.0

301.06

335.93

ng/l

0.55

127

1006

Other respiratory disorders and diseases

536

0.69

1.48

1.1

1.0

280.88

325.82

ng/l

0.60

355

Other diseases of the respiratory system

536

0.69

1.48

1.1

1.0

280.88

325.82

ng/l

0.60

355

Abnormal spermatozoa

392

0.64

1.47

1.0

585.10

304.19

ng/l

0.59

266

Hyperlipidaemia, other/unspecified

145

1103

1.21

1.47

1.0

308.16

343.91

ng/l

0.87

112

738

Interstitial lung disease endpoints

416

0.65

1.47

1.0

289.19

324.61

ng/l

0.28

274

Interstitial lung disease

416

0.65

1.47

1.0

289.19

324.61

ng/l

0.28

274

Hypogonadotropic hypogonadism

2.23

1.46

1.0

176.30

209.00

ng/l

—

Dilated cardiomyopathy

330

0.60

1.46

1.0

260.73

311.27

ng/l

0.40

226

Superficial injury of forearm

171

1.58

1.45

1.0

276.67

310.33

ng/l

0.53

115

Dialysis, with operation codes

354

0.62

1.45

1.0

319.94

310.27

ng/l

0.07

254

Dysplasia of cervi uteri

319

0.66

1.44

1.0

318.00

333.23

ng/l

0.10

232

Polycystic ovarian syndrome, consortium definition

185

923

1.19

1.44

1.0

291.25

377.82

ng/l

1.32

128

674

Examination and encounter for administrative purposes

1.92

1.44

1.0

231.71

354.14

ng/l

—

Small fibre neuropathy

1.98

1.43

1.1

1.0

156.50

318.63

ng/l

—

Anti-inflammatory and antirheumatic products, non-steroids

299

1.31

1.42

1.0

253.22

333.33

ng/l

2.51

212

Myocardial infarction, with ST-elevation

472

0.68

1.42

1.0

388.62

312.17

ng/l

0.52

312

Early onset COPD

682

0.73

1.41

1.0

335.03

333.16

ng/l

0.01

475

Ménière disease

229

1.49

1.41

1.0

292.50

327.86

ng/l

0.36

145

Malignant neoplasm of breast, ER-positive, including Hilmo

772

0.78

1.41

1.0

319.10

346.01

ng/l

0.42

553

ILD, hospital admissions

411

0.66

1.40

1.0

289.19

326.10

ng/l

0.29

271

Anterior Iridocyclitis

475

1.33

1.39

1.0

313.72

322.16

ng/l

0.11

341

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

422

0.66

1.39

1.0

329.17

305.82

ng/l

0.17

295

Allergic asthma (mode)

431

1.34

1.38

1.0

322.45

347.65

ng/l

0.22

300

Enthesopathies of lower limb, excluding foot

511

1.31

1.37

1.0

276.38

400.42

ng/l

1.02

386

Arthrosis

250

1189

1.15

1.37

1.0

324.34

312.53

ng/l

0.15

177

854

Coxarthrosis, primary, with hip surgery

126

1427

0.83

1.37

1.0

368.92

328.95

ng/l

0.25

976

Myocardial infarction, strict

132

1135

0.83

1.37

1.0

305.10

336.64

ng/l

0.68

797

Excessive vomiting in pregnancy

104

1.73

1.36

1.0

291.92

345.54

ng/l

0.54

Inflammatory diseases of prostate (prostatitis)

314

1.40

1.36

1.1

1.0

467.20

311.14

ng/l

0.57

212

101

1146

0.81

1.36

1.0

318.02

350.51

ng/l

0.66

755

Endometriosis

425

1.27

1.36

1.0

343.85

337.38

ng/l

0.07

302

Medicines for HER+ breast cancer

963

0.79

1.36

1.1

1.0

326.44

376.27

ng/l

0.52

681

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

564

1.30

1.36

1.0

312.66

314.07

ng/l

0.01

405

Diaphragmatic hernia

127

1047

1.21

1.36

1.0

281.49

338.88

ng/l

1.38

730

Allergic asthma (mode), excluding more controls

433

1.33

1.35

1.0

322.45

356.02

ng/l

0.31

299

Drug-induced osteoporosis with pathological fracture

0.00

1.35

0.0

1.0

—

278.81

—

First line medication for Crohn's disease

287

1764

0.88

1.34

1.0

414.24

311.44

ng/l

0.38

204

1259

Palmar fascial fibromatosis [Dupuytren]

418

1.34

1.33

1.0

289.86

340.94

ng/l

1.15

288

Laparoscopic left hemicolectomy

0.00

1.33

0.0

1.0

—

222.96

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

172

1419

1.18

1.33

1.1

1.0

286.34

315.28

ng/l

0.89

143

1011

Diarrhoea and gastroenteritis of presumed infectious origin

323

1886

1.13

1.32

1.0

304.63

336.54

ng/l

0.65

243

1323

Acute nasopharyngitis (common cold)

239

1.46

1.32

1.0

219.73

289.68

ng/l

1.37

177

Other/unspecified enthesopathies, not elsewhere classified

200

1.50

1.32

1.0

319.41

358.28

ng/l

0.42

138

Glaucoma

204

1511

1.16

1.31

1.0

373.99

349.67

ng/l

0.21

133

1041

Appendectomy

140

1597

0.84

1.31

1.0

290.78

329.57

ng/l

0.71

107

1141

Other arthrosis

197

1169

1.17

1.31

1.0

286.97

315.22

ng/l

0.96

148

840

Oligomenorrhoea

0.00

1.31

0.0

1.0

—

441.33

—

COPD differential diagnosis

267

1168

1.15

1.31

1.0

289.12

337.97

ng/l

2.11

198

822

ILD differential diagnosis

267

1168

1.15

1.31

1.0

289.12

337.97

ng/l

2.11

198

822

ILD medications: immunosuppressive drugs

156

1712

0.85

1.31

1.0

332.73

329.88

ng/l

0.03

116

1240

Heart failure, not strict

227

1773

0.87

1.31

1.0

304.83

344.94

ng/l

0.79

165

1263

Leisure time condition

385

1.35

1.30

1.0

372.15

324.97

ng/l

0.25

262

Abnormalities of heart beat

111

889

1.23

1.30

1.0

276.91

347.29

ng/l

3.14

605

Other disorders of bladder

292

1.41

1.30

1.0

240.62

320.34

ng/l

1.79

190

Benign neoplasm: Sigmoid colon

551

1.29

1.0

279.96

322.31

ng/l

0.74

378

Functional dyspepsia

657

1.26

1.29

1.0

280.55

337.22

ng/l

1.51

452

Ulcer of lower limb, not elsewhere classified

379

0.66

1.29

1.0

329.70

324.92

ng/l

0.03

252

Malignant neoplasm of head and neck

244

0.57

1.29

1.0

288.11

330.85

ng/l

—

151

Assault

193

1.50

1.29

1.0

273.54

288.65

ng/l

0.14

139

Special screening examination for neoplasms

1.76

1.29

1.2

1.0

337.73

358.70

ng/l

0.13

Phakomatoses, not elsewhere classified

2.80

1.29

1.2

1.0

191.00

250.90

ng/l

—

Keratitis

103

837

1.23

1.28

1.0

285.81

322.02

ng/l

0.75

592

Acute and subacute iridocyclitis

447

1.32

1.28

1.1

1.0

300.74

323.48

ng/l

0.36

322

Covid-19 suspected case

378

1.35

1.28

1.0

290.64

312.26

ng/l

0.28

270

Abdominal aortic aneurysm (AAA)

241

0.57

1.27

1.0

245.00

311.16

ng/l

—

150

Tooth eruption problems

1.75

1.27

1.0

230.30

271.16

ng/l

—

Vitamin deficiency

1.79

1.27

1.0

208.50

302.56

ng/l

—

Vitamin deficiency, wide

1.79

1.27

1.0

208.50

302.56

ng/l

—

Malignant neoplasm of breast

101

810

0.81

1.26

1.0

650.38

342.53

ng/l

0.43

585

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

483

0.70

1.26

1.0

266.81

331.81

ng/l

2.26

318

COPD/asthma related infections

339

1510

1.12

1.26

1.0

273.66

358.30

ng/l

2.56

243

1077

COPD/asthma/ILD related infections

339

1510

1.12

1.26

1.0

273.66

358.30

ng/l

2.56

243

1077

Ulcer of oesophagus

170

1.53

1.26

1.0

242.08

288.73

ng/l

0.68

105

Other menopausal disorders

411

0.75

1.26

1.0

299.49

338.59

ng/l

0.63

296

Episcleritis

1.74

1.25

1.1

1.0

326.82

293.86

ng/l

0.33

Oxicams

297

1.30

1.23

1.0

288.33

334.86

ng/l

0.88

210

Left ventricular outflow tract obstruction (LVOTO), broad definition

253

0.59

1.23

1.0

303.70

305.97

ng/l

—

183

Other noninflammatory disorders of vagina

139

1.59

1.23

1.0

288.47

373.45

ng/l

0.89

Other diseases of biliary tract

215

0.56

1.23

1.0

296.71

335.40

ng/l

—

145

Other symptoms and signs involving the circulatory and respiratory systems

147

1.57

1.22

1.0

329.63

312.33

ng/l

0.07

Aneurysms, operations, SAH

407

1.33

1.22

1.0

353.70

338.30

ng/l

0.11

280

Brachial plexus disorders

155

1.55

1.22

1.0

303.21

285.70

ng/l

0.20

112

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

832

0.79

1.22

1.1

1.0

791.40

326.10

ng/l

0.51

616

Diabetes insipidus

2.65

1.22

1.0

191.40

262.27

ng/l

—

Unspecified haematuria

145

1014

1.19

1.21

1.0

319.11

329.52

ng/l

0.18

106

686

Retinal detachment with retinal break

356

1.35

1.21

1.1

1.0

502.82

305.98

ng/l

0.87

239

Chronic kidney disease

827

0.78

1.21

1.0

295.14

332.74

ng/l

0.78

544

Abnormal findings on examination of blood, without diagnosis

159

1243

1.18

1.21

1.0

281.12

321.10

ng/l

1.32

114

857

Chronic diseases of tonsils and adenoids

189

1383

0.86

1.20

1.0

312.35

309.86

ng/l

0.04

142

1004

Car occupant injured in other and unspecified transport accidents

348

1.35

1.20

1.1

1.0

286.27

316.16

ng/l

0.32

242

Melanocytic naevi

673

0.76

1.20

1.0

276.08

333.27

ng/l

0.93

471

Other noninfective gastroenteritis and colitis

531

1.28

1.19

1.0

246.24

332.07

ng/l

4.16

368

Candidiasis

647

1.25

1.19

1.0

276.58

338.04

ng/l

1.92

453

Benign neoplasms

301

1473

1.13

1.19

1.0

317.00

309.86

ng/l

0.16

224

1035

Malignant immunoproliferative diseases

2.33

1.19

1.2

1.0

272.83

236.43

ng/l

—

Meniscus derangement

202

1179

1.15

1.19

1.0

338.72

313.65

ng/l

0.68

154

848

Deviated nasal septum

114

944

1.21

1.19

1.1

1.0

261.49

314.51

ng/l

2.38

667

Viral conjunctivitis

2.32

1.19

1.0

280.83

257.93

ng/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.31

1.18

1.2

1.0

266.67

257.53

ng/l

—

Insulin, fast-acting

107

882

1.21

1.17

1.1

1.0

339.74

317.65

ng/l

0.25

616

Disorders of lacrimal system

139

1172

1.18

1.17

1.0

314.77

354.50

ng/l

0.48

818

Tinnitus

613

1.26

1.17

1.0

290.07

337.99

ng/l

0.92

442

Other and unspecified nerve root and plexus disorders, also in other diseases

489

1.29

1.17

1.0

310.84

315.07

ng/l

0.05

345

Status post-ami

658

0.79

1.17

1.0

311.13

345.34

ng/l

0.56

447

Nephropathy related operations

322

0.65

1.17

1.0

294.33

307.37

ng/l

0.09

227

Superficial injury of hip and thigh

324

1.36

1.17

1.0

330.97

305.89

ng/l

0.21

212

Neuroendocrine tumor and carcinoma of small intestine

0.00

1.16

0.0

1.0

—

275.77

—

Portal vein thrombosis

0.00

1.16

0.0

1.0

—

222.73

—

Frostbite

2.52

1.15

1.0

345.80

269.45

ng/l

—

Pedestrian injured in other and unspecified transport accidents

2.52

1.15

1.0

175.00

244.00

ng/l

—

Postpartum hemorraghe, parous women as controls

243

0.63

1.15

1.0

452.67

326.39

ng/l

0.56

191

Malignant neoplasm of breast, ER-negative, including Hilmo

615

0.76

1.15

1.0

1067.20

352.15

ng/l

0.47

429

Benign neoplasm of other and unspecified endocrine glands

334

1.35

1.14

1.0

254.69

323.71

ng/l

1.56

226

Malignant neoplasm of heart, mediastinum and pleura

0.00

1.14

0.0

1.0

—

323.29

—

Fracture of shoulder and upper arm

110

912

1.21

1.14

1.0

279.17

333.92

ng/l

1.32

634

Benign mammary dysplasia

317

1.36

1.14

1.0

330.06

348.83

ng/l

0.19

224

Malignant neoplasm of breast, including Hilmo

104

815

0.83

1.14

1.0

647.25

342.86

ng/l

0.43

589

Malignant neoplasm of breast, HER2-negative, including Hilmo

104

815

0.83

1.14

1.0

647.25

342.86

ng/l

0.43

589

Benign neoplasm: Colon, unspecified

757

0.78

1.14

1.0

347.12

336.54

ng/l

0.10

519

Achilles tendinitis

241

1.41

1.13

1.0

297.39

330.87

ng/l

0.32

184

Inflammatory diseases of female pelvic organs

155

973

1.17

1.13

1.0

302.56

372.90

ng/l

0.97

117

696

Insulin, fast-acting or short human

108

896

1.21

1.12

1.1

1.0

337.67

313.18

ng/l

0.29

628

Skin changes due to chronic exposure to nonionizing radiation

1084

0.82

1.12

1.0

321.26

345.83

ng/l

0.46

708

Other condition

301

1.36

1.12

1.0

330.61

324.55

ng/l

0.05

210

Trochanteric bursitis

327

1.35

1.11

1.0

334.03

368.39

ng/l

0.27

226

Hypertensive heart and/or renal disease

631

0.79

1.11

1.0

292.63

355.94

ng/l

1.39

421

Other specified and unspecified retinal disorders

1.79

1.11

1.0

440.38

255.50

ng/l

—

Asthma (only as main-diagnosis), excluding more controls

224

1123

1.14

1.11

1.0

308.19

340.41

ng/l

0.83

150

793

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

145

1203

1.17

1.10

1.0

320.10

346.71

ng/l

0.30

105

868

Allergic conjunctivitis

150

1251

1.17

1.10

1.0

321.59

344.05

ng/l

0.26

109

903

Other diseases of blood and blood-forming organs, wide

584

0.75

1.10

1.0

321.97

332.68

ng/l

0.11

409

Radiculopathy

380

1.32

1.10

1.1

1.0

253.41

341.45

ng/l

3.17

274

Neuralgia and neuritis, unspecified

104

1.64

1.09

1.0

226.10

337.47

ng/l

—

Other congenital malformations

201

1.44

1.09

1.0

241.86

317.28

ng/l

1.52

131

Second line medication for Crohn's disease

135

1582

0.85

1.09

1.0

332.50

332.95

ng/l

0.00

101

1118

ILD, hospital admissions 1, main diag only

375

0.69

1.08

1.0

289.19

327.07

ng/l

0.30

248

Type 1 diabetes, wide definition, subgroup 1

398

1.31

1.08

1.0

324.98

316.23

ng/l

0.08

282

Other follicular disorders

128

1.57

1.08

1.0

311.69

289.72

ng/l

0.16

Benign neoplasm: Colon

201

1682

1.14

1.08

1.0

301.78

349.34

ng/l

0.97

139

1164

Diseases of pulp and periapical tissues, including avohilmo

331

1541

1.11

1.08

1.0

329.59

317.49

ng/l

0.20

237

1080

Primary open-angle glaucoma, strict

745

1.22

1.08

1.0

426.93

331.45

ng/l

0.58

491

L04AX Other immunosuppressants

132

1548

0.85

1.07

1.0

336.02

334.31

ng/l

0.02

1094

L02BB Anti-androgens

255

0.63

1.07

1.0

328.44

326.22

ng/l

—

161

Malignant melanoma of skin

327

0.67

1.07

1.0

263.00

334.26

ng/l

0.51

211

Other strabismus

415

1.30

1.07

1.0

315.24

325.95

ng/l

0.09

295

Malignant neoplasm of breast, HER-negative

548

0.75

1.07

1.0

1165.61

361.44

ng/l

0.47

374

Insulin, fast-acting (human)

244

1.40

1.07

1.0

272.20

317.95

ng/l

0.82

166

Acute gastritis

169

1.48

1.07

1.0

297.32

302.59

ng/l

0.05

103

Enlarged lymph nodes

321

1.34

1.07

1.0

290.57

337.61

ng/l

1.06

234

Glaucoma suspect

124

1049

1.18

1.07

1.0

400.57

320.64

ng/l

0.59

722

Other diseases of liver

455

0.72

1.06

1.0

285.91

321.48

ng/l

0.31

326

Other diseases of oesophagus

219

1.42

1.06

1.0

250.09

305.93

ng/l

0.72

136

Myalgia

515

1.26

1.05

1.0

325.12

339.51

ng/l

0.10

368

Other maltreatment syndromes

2.13

1.05

1.0

312.43

214.45

ng/l

—

Erysipelas

248

1683

1.13

1.05

1.0

267.09

345.66

ng/l

2.56

162

1203

Pulmonary heart disease, diseases of pulmonary circulation

891

0.81

1.04

1.0

270.35

328.72

ng/l

1.65

609

Nonspecific lymphadenitis

124

0.48

1.04

1.0

269.67

310.48

ng/l

—

Excluding asthma or asthma-COPD overlap

264

1176

1.13

1.04

1.0

288.53

337.74

ng/l

2.13

196

825

Liquid cancers, helper endpoint

108

1121

0.84

1.04

1.0

307.68

334.80

ng/l

0.41

769

Nasal polyp

525

1.26

1.04

1.0

292.20

315.75

ng/l

0.38

363

Other protozoal intestinal diseases

2.07

1.03

1.1

1.0

358.71

241.48

ng/l

—

Asthma (diagnoses ohter than nonallergic)

264

1958

1.12

1.02

1.0

294.93

337.87

ng/l

1.03

190

1388

Polypectomy (DHB20)

171

1.47

1.02

1.0

257.75

314.52

ng/l

1.06

111

Fracture of lower leg, including ankle

175

1512

1.15

1.02

1.0

290.84

345.12

ng/l

1.07

122

1071

Soft tissue disorders related to use, overuse and pressure

744

1.21

1.01

1.0

293.37

378.21

ng/l

0.86

526

Disorders of breast

129

999

1.17

1.01

1.0

297.32

373.00

ng/l

1.12

716

Panniculitis affecting regions of neck and back

1.77

1.00

1.1

1.0

202.83

310.63

ng/l

—

Other retinal disorders

217

1496

1.13

1.00

1.0

304.40

320.50

ng/l

0.38

149

1025

Ischemic heart diseases

308

1667

1.11

1.00

1.0

289.79

345.29

ng/l

1.47

209

1220

Chronic gastritis

781

1.20

1.00

1.0

301.49

335.99

ng/l

0.57

523

Benign neoplasm: Stomach

248

1.37

0.99

1.1

1.0

364.58

331.86

ng/l

0.23

160

Biological medication for rheuma

321

0.68

0.99

1.0

277.76

316.29

ng/l

0.74

235

Fentanyl

261

0.65

0.99

1.1

1.0

467.91

370.32

ng/l

0.21

169

Diagnoses used for exclusion with ILD

655

1.22

0.99

1.0

303.43

322.79

ng/l

0.34

451

Spondylolisthesis/Spondylolysis

440

1.27

0.99

1.0

266.66

343.17

ng/l

2.56

321

Noninfective enteritis and colitis

131

1121

1.17

0.99

1.0

272.53

351.67

ng/l

1.36

788

Alcoholic gastritis

2.18

0.98

1.2

1.0

303.60

252.00

ng/l

—

Asthma (only as main-diagnosis)

227

1165

1.13

0.98

1.0

307.91

338.10

ng/l

0.77

152

820

Pulmonary eosinophilia, not elsewhere classified

0.00

0.98

0.0

1.0

—

273.35

—

Acquired absence of organs, not elsewhere classified

0.00

0.98

0.0

1.0

—

269.61

—

Deforming dorsopathies

647

1.22

0.98

1.0

259.24

389.96

ng/l

1.63

479

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

820

1.20

0.97

1.0

249.06

333.15

ng/l

3.19

579

Mesothelioma

0.00

0.97

0.0

1.0

—

352.30

—

Myocardial infarction, unclassifiable

521

0.77

0.97

1.0

298.47

322.27

ng/l

0.33

330

Universal erythroderma, KELA reimbursement

0.00

0.97

0.0

1.0

—

228.00

—

Inflammation of lacrimal passages (acute and unspecified)

0.00

0.97

0.0

1.0

—

259.69

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.96

0.0

1.0

—

260.85

—

Subarachnoid haemorrhage

258

1.36

0.96

1.0

345.29

323.23

ng/l

0.12

168

Degenerative macular diseases

310

1.33

0.96

1.0

324.63

308.57

ng/l

0.15

198

Pleural plaque

283

0.67

0.96

1.0

240.57

317.24

ng/l

0.88

172

Other and unspecified tonsillitis

446

1.24

0.95

1.1

1.0

259.00

298.50

ng/l

0.71

329

Diseases of arteries, arterioles and capillaries

190

1588

0.88

0.95

1.0

300.13

325.14

ng/l

0.76

134

1082

Diseases of liver

967

0.83

0.95

1.0

323.79

319.88

ng/l

0.04

684

Antihypertensive medication - note that there are other indications

133

603

1.17

0.95

1.0

277.48

331.27

ng/l

1.14

471

Cerebral palsy and other paralytic syndromes

242

1.37

0.94

1.0

244.33

319.14

ng/l

2.45

155

Hypothermia

1.90

0.94

1.0

305.43

240.65

ng/l

—

Other pulmonary diagnosis

262

1176

1.12

0.94

1.0

288.92

337.74

ng/l

2.08

195

825

Alcohol abuse counselling and surveillance

2.23

0.93

1.2

1.0

201.00

232.07

ng/l

—

L04AA Selective immunosuppressants

534

0.77

0.93

1.0

386.81

334.40

ng/l

0.51

382

Cerebral aneurysm, nonruptured

217

1.39

0.93

1.0

434.71

336.45

ng/l

0.71

148

Disorders of conjunctiva

239

1718

1.12

0.93

1.0

316.99

336.52

ng/l

0.30

173

1227

L02BA Anti-estrogens

374

0.72

0.93

1.1

1.0

298.80

360.16

ng/l

0.87

259

Viral warts

420

0.74

0.92

1.0

329.94

322.95

ng/l

0.08

298

Mouth breathing

129

1110

1.16

0.92

1.0

270.92

313.93

ng/l

1.49

788

Follow-up examination after treatment for malignant neoplasms

175

1.43

0.92

1.1

1.0

307.83

360.46

ng/l

0.71

125

Disease of hard tissues of teeth, NOS

184

846

1.14

0.92

1.0

300.35

333.32

ng/l

0.85

135

591

Polyarthrosis

580

1.22

0.91

1.0

323.26

339.09

ng/l

0.13

395

Viral hepatitis

118

1.53

0.90

1.1

1.0

216.82

262.27

ng/l

0.69

Coxibs

298

1.24

0.90

1.0

272.38

334.01

ng/l

1.32

211

Other disorders of veins

101

1182

0.85

0.90

1.0

387.47

345.93

ng/l

0.23

853

Myocardial infarction, without ST-elevation

104

1113

0.85

0.90

1.0

303.89

334.70

ng/l

0.61

751

Other disorders of bone

420

1.26

0.89

1.0

268.14

324.82

ng/l

1.54

302

Other hammer toe(s) (acquired)

479

0.77

0.89

1.1

1.0

367.27

344.28

ng/l

0.17

326

Dental caries

559

1.22

0.89

1.0

787.31

341.51

ng/l

0.49

408

Dermatophytosis

348

0.72

0.89

1.0

232.61

309.07

ng/l

2.23

243

Peripheral artery operations in Hilmo

336

0.71

0.89

1.0

285.00

315.92

ng/l

0.23

211

Exposure to other specified factors

222

1825

1.12

0.89

1.0

455.02

309.96

ng/l

0.47

172

1296

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

127

1.50

0.88

1.0

257.08

334.36

ng/l

1.11

Other and unspecified injuries of wrist and hand

1.79

0.88

1.1

1.0

209.60

267.36

ng/l

—

Gout, FINNGEN

879

0.83

0.87

1.0

275.86

323.59

ng/l

1.27

592

Gastroduodenal ulcer

691

1.20

0.87

1.0

319.97

330.74

ng/l

0.15

466

Injuries to the knee and lower leg

370

1883

1.09

0.87

1.0

296.04

338.76

ng/l

1.01

269

1327

Iridocyclitis

530

1.23

0.86

1.0

314.53

321.02

ng/l

0.08

374

Seropositive rheumatoid arthritis, strict definition

380

0.74

0.86

1.0

350.43

335.18

ng/l

0.12

261

Haemorrhage, not elsewhere classified

1.72

0.86

1.1

1.0

362.40

292.87

ng/l

—

Lung diseases due to external agents

325

1.29

0.86

1.0

295.44

314.79

ng/l

0.18

214

ILD medications

303

1803

0.91

0.86

1.0

290.65

331.03

ng/l

0.99

214

1290

Maltreatment syndromes

1.82

0.86

1.1

1.0

366.50

230.47

ng/l

—

Cellulitis

522

1.23

0.85

1.0

316.80

320.47

ng/l

0.04

365

Other and unspecified effects of external causes

531

1.23

0.85

1.0

314.67

316.23

ng/l

0.02

381

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

686

1.20

0.85

1.0

727.67

317.52

ng/l

0.47

483

Seropositive rheumatoid arthritis

733

0.81

0.85

1.0

336.59

324.18

ng/l

0.15

495

Ulcerative proctitis

104

1.54

0.84

1.0

223.36

278.83

ng/l

0.72

525

0.79

0.84

1.0

340.57

337.91

ng/l

0.03

328

Ganglion

478

1.24

0.84

1.0

387.52

413.47

ng/l

0.11

347

Divergent concomitant strabismus

137

1.46

0.84

1.1

1.0

282.42

302.35

ng/l

0.13

Conjunctivitis

208

1556

1.12

0.83

1.0

312.41

338.40

ng/l

0.39

149

1121

Superficial injury of wrist and hand

362

1.27

0.83

1.0

275.08

323.29

ng/l

0.69

258

Sequelae of injuries of upper limb

222

1.35

0.83

1.1

1.0

286.83

314.68

ng/l

0.34

149

DVT of lower extremities

524

0.78

0.83

1.0

343.93

321.47

ng/l

0.21

365

Ischaemic heart disease, wide definition

297

1676

1.10

0.83

1.0

291.16

346.65

ng/l

1.41

206

1211

Haemorrhage from respiratory passages

115

894

1.16

0.83

1.0

294.68

351.31

ng/l

1.41

601

Other/unspecified seropositive rheumatoid arthritis

723

0.82

0.83

1.0

340.12

337.49

ng/l

0.03

494

Thyrotoxicosis with diffuse goitre

285

0.70

0.83

1.0

282.14

337.96

ng/l

0.45

204

Asthma mixed form (mode), excluding more controls

114

0.52

0.82

1.0

545.50

353.71

ng/l

—

Other and unspecified vascular occlusions

231

1.34

0.82

1.0

295.15

296.85

ng/l

0.01

143

Other viral diseases

656

1.20

0.82

1.0

292.42

303.04

ng/l

0.12

479

Dissociative [conversion] disorders

1.88

0.82

1.0

190.17

307.00

ng/l

—

Corneal ulcer

399

1.25

0.81

1.0

232.22

313.29

ng/l

2.32

286

Polymyalgia rheumatica

353

0.74

0.81

1.0

368.37

322.95

ng/l

0.38

226

Non-Hodgkin lymphoma, all, including Hilmo

421

0.76

0.81

1.0

407.91

332.71

ng/l

0.46

268

Superficial injury of thorax

337

1.28

0.81

1.0

294.12

311.38

ng/l

0.20

231

Acute renal failure

610

0.80

1.0

322.39

317.71

ng/l

0.04

410

Acute appendicitis, with complications

510

0.78

0.80

1.1

1.0

327.17

318.09

ng/l

0.09

355

Polyarthropathies

203

1188

1.12

0.80

1.0

328.86

312.60

ng/l

0.19

146

853

Irregular menses

106

719

1.16

0.80

1.0

248.87

382.78

ng/l

1.88

534

Systemic connective tissue disorders

915

0.84

0.80

1.0

350.50

332.78

ng/l

0.24

617

Injury of muscle and tendon at lower leg level

397

0.75

0.80

1.0

263.82

311.91

ng/l

0.78

280

Leiomyosarcoma, including Hilmo

0.00

0.79

0.0

1.0

—

276.07

—

Melanoma of uvea

0.00

0.79

0.0

1.0

—

284.43

—

Sub-endpoint used in defining T1D endpoints

581

1.20

0.79

1.0

311.04

307.37

ng/l

0.04

404

Asthma, unspecified (mode)

169

1130

1.13

0.79

1.0

269.52

338.15

ng/l

3.47

124

794

Appendicitis, broad definition

183

1849

0.89

0.79

1.1

1.0

279.67

332.15

ng/l

1.46

142

1335

Varus deformity, not elsewhere classified

0.00

0.79

0.0

1.0

—

421.40

—

Carcinoid syndrome

0.00

0.79

0.0

1.0

—

253.36

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.79

0.0

1.0

—

237.92

—

Accidental poisoning by and exposure to alcohol

0.00

0.79

0.0

1.0

—

251.08

—

Pulmonary heart disease

816

0.83

0.79

1.0

261.87

329.63

ng/l

2.08

561

Other diseases of upper respiratory tract

355

1703

1.09

0.78

1.0

299.84

321.85

ng/l

0.81

256

1196

Other and unspecified haemorrhagic conditions

0.00

0.78

0.0

1.0

—

247.56

—

Pulmonary embolism

815

0.83

0.78

1.0

261.87

329.81

ng/l

2.09

561

Urticaria

611

1.20

0.77

1.0

282.75

330.34

ng/l

1.10

438

Type 1 diabetes, wide definition

420

1.24

0.77

1.0

324.98

317.62

ng/l

0.07

293

Disorders of refraction and accommodation

509

1.21

0.77

1.0

345.02

319.84

ng/l

0.24

369

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

835

0.84

0.76

1.0

237.88

326.53

ng/l

2.26

608

Glucagon-like peptide-1 (GLP-1) analogues

835

0.84

0.76

1.0

237.88

326.53

ng/l

2.26

608

Female infertility, cervical, vaginal, other or unspecified origin

345

0.79

0.76

1.0

271.21

336.54

ng/l

1.47

254

Varicose veins

180

1516

0.90

0.76

1.0

326.22

349.51

ng/l

0.36

118

1078

Other congenital malformations of skin

132

1.44

0.75

1.0

275.46

292.23

ng/l

0.14

Diseases of appendix

186

1864

0.90

0.75

1.1

1.0

282.51

332.86

ng/l

1.39

145

1346

Raynaud syndrome

166

1.39

0.75

1.0

288.06

302.06

ng/l

0.10

104

Diseases of middle ear and mastoid

938

0.86

0.75

1.0

294.16

315.07

ng/l

0.38

662

Tumor necrosis factor alpha inhibitors

279

0.72

0.75

1.0

282.07

315.74

ng/l

0.53

203

Seropositive rheumatoid arthritis, wide

724

0.83

0.75

1.0

336.59

337.77

ng/l

0.01

495

Speech therapy

678

1.18

0.75

1.0

325.51

327.83

ng/l

0.01

463

Other systemic involvement of connective tissue (FG)

682

0.82

0.74

1.0

357.59

328.47

ng/l

0.37

461

Open wound of wrist and hand

120

1026

1.14

0.74

1.0

251.05

313.95

ng/l

3.54

731

Endometriosis of rectovaginal septum and vagina

141

1.42

0.74

1.1

1.0

365.73

387.99

ng/l

0.10

Myeloproliferative diseases

220

0.68

0.74

1.0

277.30

320.19

ng/l

—

144

Orchitis and epididymitis

201

1.35

0.74

1.0

275.33

301.26

ng/l

0.38

133

Conduction disorders

815

0.85

0.74

1.0

280.71

348.77

ng/l

2.73

551

Hydrocele

271

1.29

0.74

1.0

265.35

302.94

ng/l

0.50

177

Primary open-angle glaucoma

106

889

1.15

0.74

1.0

405.71

330.29

ng/l

0.53

591

Antenatal screening

164

0.72

0.74

1.0

245.31

279.09

ng/l

0.68

139

UC patients in KELA-register (code 208), prior to 1994

108

1.49

0.73

1.1

1.0

479.20

279.93

ng/l

—

Other sexually transmitted chlamydial diseases

1.84

0.73

1.0

230.43

212.33

ng/l

—

Opioids

300

1430

1.09

0.73

1.0

276.84

331.29

ng/l

3.06

222

1006

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

2.02

0.73

1.2

1.0

301.00

241.79

ng/l

—

Asthma, unspecified (mode), excluding more controls

164

1095

1.12

0.73

1.0

268.15

341.03

ng/l

3.78

122

772

Injuries to the ankle and foot

155

1543

0.89

0.72

1.0

284.65

327.59

ng/l

0.79

118

1111

Asthma mixed form (mode)

108

0.55

0.72

1.0

545.50

358.25

ng/l

—

Acetic acid derivatives and related substances

298

1.20

0.72

1.0

287.47

334.01

ng/l

0.70

211

Rheumatoid arthritis, including avohilmo

1066

0.86

0.72

1.0

325.45

325.96

ng/l

0.01

736

Caries of enamel

225

1783

0.91

0.71

1.0

284.92

329.57

ng/l

1.06

158

1299

Hypoparathyroidism

1.58

0.71

1.0

201.83

323.04

ng/l

—

Lateral epicondylitis

317

1.26

0.71

1.0

301.61

351.94

ng/l

0.49

230

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

709

0.83

0.71

1.0

340.12

338.32

ng/l

0.02

488

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

334

0.75

0.71

1.0

257.52

313.70

ng/l

1.15

232

Other diseases of the digestive system

858

1.15

0.71

1.0

293.27

326.13

ng/l

0.74

583

Herpesviral [herpes simplex] infections

241

0.70

0.71

1.0

240.80

333.15

ng/l

—

165

Other protozoal intestinal diseases

1.93

0.71

1.2

1.0

401.00

219.13

ng/l

—

Use of antiglaucoma preparations and miotics

177

1.36

0.70

1.0

295.53

310.10

ng/l

0.13

111

Atopic dermatitis, strict definition

408

1.22

0.70

1.1

1.0

249.69

318.91

ng/l

2.20

294

Acute pharyngitis

236

1.30

0.70

1.0

287.85

304.55

ng/l

0.13

168

Diseases of the skin and subcutaneous tissue

321

1485

1.08

0.70

1.0

295.59

348.36

ng/l

1.14

221

1054

Collagenous colitis

212

1.32

0.70

1.0

278.86

322.76

ng/l

0.59

140

Allergic contact dermatitis

265

1.28

0.69

1.0

367.92

341.32

ng/l

0.20

182

Bell's palsy

283

1.27

0.69

1.0

318.52

324.87

ng/l

0.07

196

Asthma, hospital admissions , main diagnosis only

237

1911

1.09

0.69

1.0

306.52

337.20

ng/l

0.58

159

1364

Disorder of lipoprotein metabolism, unspecified

382

1.23

0.69

1.0

317.18

343.34

ng/l

0.27

250

Burns and corrosions

285

0.74

0.68

1.1

1.0

287.79

305.25

ng/l

0.10

196

Nummular dermatitis

213

1.32

0.68

1.0

253.05

314.01

ng/l

1.12

145

Scleritis and episcleritis

110

1.46

0.68

1.1

1.0

326.82

290.94

ng/l

0.39

Other and unspecified urticaria

392

1.23

0.67

1.0

253.48

334.99

ng/l

2.27

272

Postpartum hemorraghe, all women as controls

246

0.72

0.67

1.0

452.67

302.48

ng/l

0.72

193

Other viral diseases, not elsewhere classified

435

1.21

0.67

1.0

292.61

314.72

ng/l

0.23

308

Familial hypercholesterolemia

447

1.21

0.67

1.0

274.00

345.50

ng/l

1.39

292

Gonarthrosis [arthrosis of knee](FG)

279

1493

1.09

0.67

1.0

303.03

337.01

ng/l

0.62

198

1074

Deep endometriosis

153

1.37

0.67

1.0

365.73

338.89

ng/l

0.12

102

Separation of retinal layers (serosa)

1.49

0.66

1.1

1.0

193.67

251.92

ng/l

—

Diseases of external ear

100

873

1.15

0.66

1.0

268.63

328.38

ng/l

1.67

614

Infections of the skin and subcutaneous tissue

161

1434

1.11

0.66

1.0

286.22

337.98

ng/l

0.95

116

1019

Fitting and adjustment of other devices

120

957

1.13

0.66

1.0

366.99

344.78

ng/l

0.34

619

Other pleural conditions

260

0.73

0.66

1.1

1.0

567.08

313.67

ng/l

0.73

160

Myocardial infarction

153

1198

0.90

0.65

1.0

301.24

333.27

ng/l

0.80

101

847

Other (seronegative) rheumatoid arthritis, wide

472

0.80

0.65

1.0

349.24

334.58

ng/l

0.14

329

Sulfonylureas

841

0.87

0.65

1.1

1.0

344.65

353.77

ng/l

0.07

560

Paralytic ileus and intestinal obstruction

688

1.16

0.65

1.0

290.67

341.84

ng/l

1.42

471

DVT of lower extremities and pulmonary embolism

105

1188

0.88

0.65

1.0

295.67

329.57

ng/l

0.77

815

Haemorrhage in early pregnancy

464

1.20

0.64

1.1

1.0

391.61

337.24

ng/l

0.68

341

Carpal tunnel syndrome

194

1556

1.10

0.64

1.0

304.46

339.01

ng/l

0.62

144

1108

Inflammatory bowel disease

699

1.16

0.64

1.0

289.95

328.24

ng/l

0.65

510

Erosion of teeth , including avohilmo

450

1.20

0.63

1.0

341.79

310.64

ng/l

0.29

320

ILD, hospital admission 2, with pulmonary infections

258

0.74

0.63

1.0

267.50

348.94

ng/l

—

172

Chronic lower respiratory diseases

372

1848

1.07

0.63

1.0

282.93

339.75

ng/l

1.74

270

1315

Stomatitis and related lesions

426

0.80

0.63

1.0

311.40

319.23

ng/l

0.07

296

Other/unspecified enthesopathies of lower limb, excluding foot

129

1.40

0.63

1.0

246.17

339.57

ng/l

0.82

Adhesive capsulitis of shoulder

432

1.21

0.63

1.0

347.95

353.27

ng/l

0.04

312

Erysipelas

186

1496

1.10

0.63

1.0

268.01

322.70

ng/l

2.97

119

1054

Coxarthrosis

187

1121

1.10

0.63

1.0

316.84

317.22

ng/l

0.00

121

800

Nonsuppurative otitis media

282

0.77

0.63

1.0

338.45

325.89

ng/l

0.07

187

Secondary uncertain malignant neoplasm

392

0.79

0.62

1.0

343.48

338.63

ng/l

0.03

252

Viral warts

188

0.69

0.62

1.0

349.71

310.86

ng/l

—

127

Pedal cyclist injured in transport accident

470

1.19

0.61

1.0

278.41

316.75

ng/l

0.64

333

Mycoses

254

2039

1.08

0.61

1.0

281.07

337.05

ng/l

1.84

180

1454

Corns and callosities

147

1.36

0.61

1.1

1.0

332.40

298.06

ng/l

—

Effects of other external causes

1.67

0.61

1.0

274.40

228.44

ng/l

—

Prepatellar bursitis

113

1.42

0.61

1.0

254.27

346.38

ng/l

1.02

Other congenital malformations of upper alimentary tract

0.00

0.60

0.0

1.0

—

258.70

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

0.60

0.0

1.0

—

278.86

—

Corticotropin deficiency

0.00

0.60

0.0

1.0

—

266.91

—

Glaucoma secondary to eye inflammation

0.00

0.60

0.0

1.0

—

251.55

—

Gonarthrosis

226

1181

1.09

0.60

1.0

309.63

313.85

ng/l

0.08

156

847

Primary adrenocortical insufficiency

0.00

0.60

0.0

1.0

—

258.27

—

Wet age-related macular degeneration

421

0.81

0.60

1.1

1.0

275.45

335.46

ng/l

0.85

260

Certolizumab pegol

0.00

0.60

0.0

1.0

—

291.46

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.60

0.0

1.0

—

244.15

—

Codeine

284

1429

1.08

0.60

1.0

395.86

331.47

ng/l

0.21

205

1005

Acute drug-induced interstitial lung disorder

0.00

0.60

0.0

1.0

—

268.33

—

Aspergillosis

0.00

0.60

0.0

1.0

—

245.00

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

0.00

0.60

0.0

1.0

—

241.06

—

GI-bleeding

853

1.14

0.60

1.0

271.25

326.94

ng/l

2.29

580

Atypical facial pain

105

1.43

0.60

1.0

314.13

304.53

ng/l

—

Chronic ulcer of skin, not elsewhere classified

163

0.67

0.60

1.1

1.0

271.83

308.64

ng/l

—

106

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

307

1970

1.07

0.60

1.0

309.47

333.65

ng/l

0.48

234

1388

Adjustment and management of implanted device

488

0.82

0.59

1.0

313.56

329.61

ng/l

0.26

309

Cardiomyopathies, Secondary/extrinsic

0.00

0.59

0.0

1.0

—

246.33

—

Osteitis due to dental implant

0.00

0.59

0.0

1.0

—

252.23

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

0.00

0.59

0.0

1.0

—

272.50

—

Gastric ulcer

463

1.19

0.59

1.0

311.79

333.92

ng/l

0.24

298

Complications of medical and surgical care

229

1940

1.09

0.59

1.0

453.76

320.13

ng/l

0.40

166

1365

Heterophoria

131

1.38

0.59

1.0

249.89

299.10

ng/l

—

Ventral hernia

639

0.84

0.58

1.1

1.0

291.55

333.94

ng/l

0.64

451

Early onset COPD, excluding more controls

595

0.84

0.58

1.0

335.03

345.66

ng/l

0.08

413

Combined immunodeficiencies

0.00

0.58

0.0

1.0

—

245.08

—

Dissocial personality disorder

0.00

0.58

0.0

1.0

—

222.69

—

Misadventures to patients during surgical and medical care

345

1.22

0.58

1.0

1057.06

321.97

ng/l

0.45

235

Diseases of the digestive system

136

1218

1.11

0.58

1.0

315.68

334.57

ng/l

0.28

832

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

353

0.79

0.58

1.0

257.39

338.69

ng/l

1.84

215

Spondylopathies (FG)

282

1.24

0.58

1.0

269.05

315.93

ng/l

0.93

206

Noninfectious colitis NAS

282

1.24

0.58

1.0

218.83

327.91

ng/l

6.06

189

Visual impairment including blindness (binocular or monocular)

123

1.38

0.57

1.0

382.50

314.56

ng/l

0.43

Sequelae of other external causes

116

0.60

0.57

1.1

1.0

264.71

310.89

ng/l

—

Female infertility

349

0.83

0.57

1.0

267.64

336.12

ng/l

1.66

256

Diabetic nephropathy, excluding more controls

254

1.23

0.57

1.0

348.20

289.62

ng/l

0.62

179

Other systemic involvement of connective tissue

680

0.85

0.57

1.0

354.18

342.26

ng/l

0.13

467

Cholelithiasis

242

1802

0.93

0.57

1.0

314.97

340.88

ng/l

0.47

159

1284

Polyarthritis, unspecified

1.49

0.57

1.0

232.00

299.00

ng/l

—

Mycoses

669

0.85

0.57

1.0

276.09

327.44

ng/l

1.57

464

Demyelinating diseases of the central nervous system

132

1.37

0.57

1.2

1.0

205.58

301.16

ng/l

1.96

Hernia of abdominal wall

117

1306

0.90

0.56

1.0

276.64

321.69

ng/l

1.29

910

Polyp of the female genital tract

423

0.85

0.56

1.0

271.65

337.95

ng/l

1.87

301

Open wound of forearm

184

0.71

0.56

1.0

293.86

298.39

ng/l

—

121

Hydronephrosis

286

0.77

0.56

1.0

338.38

315.15

ng/l

0.23

188

Dermatitis and eczema

338

1961

1.07

0.56

1.0

283.73

338.80

ng/l

1.72

244

1393

Corneal degeneration

1.63

0.55

1.0

326.33

268.43

ng/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.63

0.55

1.0

357.33

231.79

ng/l

—

Malignant neoplasm of bladder

183

0.71

0.55

1.0

372.71

341.41

ng/l

—

110

Urticaria and erythema

784

1.14

0.55

1.0

278.72

326.10

ng/l

1.33

560

Benign neoplasm: Rectum

532

1.17

0.55

1.0

315.92

330.96

ng/l

0.23

360

Diabetic retinopathy

534

1.13

0.55

1.0

259.87

293.62

ng/l

0.84

377

Benign neoplasm of eye and adnexa

262

0.76

0.54

1.0

342.33

318.04

ng/l

0.16

167

Other joint disorders

245

1196

1.08

0.54

1.0

311.89

311.50

ng/l

0.01

177

859

Other abnormal findings of blood chemistry

1.42

0.54

1.0

173.00

301.32

ng/l

—

Secondary hypertension

175

1.30

0.54

1.1

1.0

304.76

346.60

ng/l

0.37

126

Other symptoms and signs involving the urinary system

258

1.24

0.53

1.0

247.88

318.73

ng/l

1.82

172

Personal history of other diseases and conditions

133

1.35

0.53

1.0

268.62

310.46

ng/l

0.45

Injuries to unspecified part of trunk, limb or body region

216

0.74

0.53

1.0

329.50

308.34

ng/l

—

141

Cholelithiasis, broad definition with cholecystitis

253

1830

0.93

0.53

1.0

315.93

339.52

ng/l

0.42

163

1305

Gestational diabetes (for exclusion)

244

0.80

0.53

1.0

252.00

306.24

ng/l

1.00

192

Inflammatory bowel disease, strict (require KELA)

460

1.17

0.53

1.0

314.71

308.68

ng/l

0.05

336

Ankylosing spondylitis

178

1.29

0.52

1.0

282.20

320.66

ng/l

0.49

133

Overexertion and strenuous or repetitive movements

223

1.26

0.52

1.0

232.65

315.75

ng/l

1.82

149

Female genital prolapse

422

1.14

0.52

1.0

297.83

337.95

ng/l

0.79

301

Toxic effects of substances chiefly nonmedicinal as to source

232

1.25

0.52

1.0

291.14

320.70

ng/l

0.31

158

Temporomandibular joint disorders, including avohilmo

842

1.12

0.52

1.0

266.54

361.06

ng/l

1.40

626

Acne vulgaris

1.50

0.51

1.2

1.0

201.67

211.63

ng/l

—

Other diseases of lip and oral mucosa

120

1083

1.11

0.51

1.0

332.38

352.12

ng/l

0.20

766

ILD, hospital admissions 3, with pneumonia sepsis

214

0.75

0.51

1.0

272.29

327.99

ng/l

—

135

Biomechanical lesions, not elsewhere classified

109

1.38

0.51

1.0

257.56

308.43

ng/l

—

Other viral diseases

507

1.16

0.50

1.0

307.57

306.33

ng/l

0.01

369

Coxarthrosis [arthrosis of hip](FG)

208

1354

1.08

0.50

1.0

332.64

342.91

ng/l

0.08

137

967

Effects of foreign body entering through natural orifice

565

1.15

0.50

1.0

315.83

301.36

ng/l

0.12

405

Chronic rhinitis, nasopharyngitis and pharyngitis

791

1.13

0.50

1.0

745.93

320.28

ng/l

0.49

561

IBD patients in KELA-register

464

1.16

0.49

1.0

314.71

315.33

ng/l

0.01

336

Aplastic and other anaemias

120

1233

0.91

0.48

1.0

327.62

342.91

ng/l

0.23

813

Injury of eye and orbit

280

1.22

0.48

1.0

286.31

320.31

ng/l

0.50

196

Complications of procedures, not elsewhere classified

250

1933

1.07

0.48

1.0

469.85

315.27

ng/l

0.53

177

1380

Dislocation, sprain and strain of joints and ligaments at neck level

253

1.23

0.48

1.0

252.55

318.63

ng/l

1.04

176

Pilonidal cyst

119

1.35

0.48

1.0

229.40

260.55

ng/l

—

Abnormal serum enzyme levels

104

912

1.11

0.48

1.0

305.04

321.37

ng/l

0.26

625

Other bacterial intestinal infections

540

1.15

0.47

1.0

267.83

328.20

ng/l

2.29

370

Decubitus ulcer and pressure area

128

1.33

0.47

1.1

1.0

395.80

305.56

ng/l

—

Hypertrophy of breast in women and men

410

1.17

0.47

1.0

306.11

331.22

ng/l

0.25

288

Chronic periodontitis, complicated

187

1717

1.08

0.47

1.0

300.99

334.07

ng/l

0.64

140

1231

Otalgia

146

1.30

0.47

1.0

243.57

300.54

ng/l

0.72

Benign neoplasm: Transverse colon

309

1.20

0.46

1.0

332.56

320.44

ng/l

0.09

209

Other specified and unspecified personality disorders

155

1.29

0.46

1.1

1.0

192.67

283.98

ng/l

2.42

103

Retinal vascular occlusion

300

1.20

0.46

1.0

281.46

306.40

ng/l

0.29

187

Ulcerative rectosigmoiditis

173

1.27

0.46

1.0

310.94

310.07

ng/l

0.01

118

Other peripheral vascular diseases

182

1.27

0.46

1.0

332.00

308.38

ng/l

0.18

112

Gout

725

0.89

0.45

1.0

275.86

326.02

ng/l

1.34

504

Venous thromboembolism

148

1553

0.92

0.45

1.0

302.10

349.45

ng/l

0.84

100

1073

Other contact dermatitis

156

1.28

0.45

1.1

1.0

299.15

316.94

ng/l

0.12

103

Outcome of delivery

0.70

0.45

1.0

181.30

275.11

ng/l

—

Problems related to lifestyle

201

1.25

0.44

1.0

288.16

328.86

ng/l

0.55

135

All influenza (not pneumonia)

329

1.19

0.44

1.1

1.0

202.79

316.68

ng/l

5.22

228

Recurrent aphthous stomatitis , including avohilmo

308

0.81

0.44

1.0

312.82

331.61

ng/l

0.21

201

Procreative management

524

1.13

0.43

1.0

313.13

318.85

ng/l

0.05

383

Other symptoms and signs involving the digestive system and abdomen

395

1.17

0.43

1.0

285.14

341.17

ng/l

1.17

270

Other/unspecified rheumatoid arthritis

307

0.81

0.43

1.0

299.71

336.00

ng/l

0.47

199

Other necrotizing vasculopathies (FG)

148

1.29

0.43

1.0

331.83

329.10

ng/l

0.01

Primary_lymphoid and hematopoietic malignant neoplasms

693

0.88

0.43

1.1

1.0

353.44

326.62

ng/l

0.22

471

Sarcoidosis

321

1.19

0.43

1.0

309.97

327.94

ng/l

0.24

221

Idiopathic gout

263

0.80

0.43

1.0

264.14

317.76

ng/l

0.92

172

Ankylosing spondylitis, ICD10

184

1.25

0.43

1.0

282.20

287.26

ng/l

0.05

125

Non-allergic asthma (mode)

484

1.15

0.43

1.0

311.49

354.40

ng/l

0.53

326

Presence of other devices

656

1.12

0.43

1.1

1.0

385.29

341.77

ng/l

0.43

421

Atopic dermatitis, strict definition with reimbursement

445

1.15

0.42

1.1

1.0

247.91

309.30

ng/l

1.96

327

Lichen planus, including avohilmo

499

1.14

0.42

1.0

281.28

334.33

ng/l

1.01

351

Other disorders of breast

239

1.21

0.42

1.1

1.0

275.59

360.16

ng/l

0.93

171

Melanoma in situ of other and unspecified parts of face

1.57

0.42

1.0

217.00

236.06

ng/l

—

Other septicaemia

113

991

1.10

0.42

1.0

296.95

350.43

ng/l

1.21

673

Other sexually transmitted chlamydial diseases

1.56

0.42

1.0

188.40

213.54

ng/l

—

AV-block

513

0.87

0.42

1.0

266.69

356.06

ng/l

2.48

329

Other aneurysm

139

0.72

0.42

1.0

238.20

305.05

ng/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

185

1.25

0.41

1.1

1.0

211.64

307.43

ng/l

2.36

115

Retinal vascular disorders

304

1.19

0.41

1.0

281.46

307.30

ng/l

0.31

189

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.0

—

279.29

—

Dermatopolymyositis, unspecified

0.00

0.41

0.0

1.0

—

283.11

—

Toxoplasmosis

0.00

0.41

0.0

1.0

—

273.25

—

Idiopathic hypercalciuria

0.00

0.41

0.0

1.0

—

293.25

—

Deformity of finger(s)

0.00

0.41

0.0

1.0

—

238.11

—

Diseases of the respiratory system

207

968

1.07

0.41

1.0

312.25

342.75

ng/l

0.67

142

681

Fenamates

218

1.18

0.41

1.0

398.96

332.13

ng/l

0.55

150

Lower leg

0.00

0.41

0.0

1.0

—

261.89

—

Anuria and oliguria

0.00

0.41

0.0

1.0

—

270.44

—

Increased muscle tone

0.00

0.41

0.0

1.0

—

234.67

—

Panhypopituitarism

1.52

0.41

1.0

299.80

249.30

ng/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.41

0.0

1.0

—

258.44

—

Other specified/unspecified nutritional deficiencies

0.00

0.41

0.0

1.0

—

261.90

—

Melanocytic naevi of lip

0.00

0.41

0.0

1.0

—

260.33

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.41

0.0

1.0

—

255.00

—

Recurrent and persistent haematuria

0.00

0.41

0.0

1.0

—

264.11

—

ILD medications: nintedanib

0.00

0.41

0.0

1.0

—

286.00

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.41

0.0

1.0

—

274.89

—

Melanoma in situ of lower limb, including hip

0.00

0.41

0.0

1.0

—

289.91

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.41

0.0

1.0

—

258.60

—

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.0

—

279.29

—

Other and unspecified disorders of pigmentation

0.00

0.41

0.0

1.0

—

258.44

—

Valgus deformity, not elsewhere classified

0.00

0.41

0.0

1.0

—

259.00

—

Other injuries of spine and trunk, level unspecified

0.00

0.41

0.0

1.0

—

232.75

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.41

0.0

1.0

—

213.40

—

Paget disease

0.00

0.41

0.0

1.0

—

278.00

—

Injury of muscle and tendon at wrist and hand level

314

1.18

0.41

1.0

252.55

313.08

ng/l

1.18

227

Infarction of spleen

0.00

0.41

0.0

1.0

—

263.10

—

Atlantoaxial subluxation

0.00

0.41

0.0

1.0

—

305.83

—

Other and unspecified acne

0.00

0.40

0.0

1.0

—

260.80

—

Use of glatiramer acetate

0.00

0.40

0.0

1.0

—

220.67

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.40

0.0

1.0

—

248.92

—

Polycystic ovarian syndrome

0.00

0.40

0.0

1.0

—

271.45

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

204

1.23

0.40

1.0

365.54

323.80

ng/l

0.20

132

Dentofacial anomalies [including malocclusion]

156

1350

0.93

0.40

1.0

286.32

340.75

ng/l

1.13

109

993

Other shoulder lesions

195

1.23

0.40

1.0

245.28

361.82

ng/l

2.58

135

Fibrosis of liver

0.00

0.40

0.0

1.0

—

273.00

—

Cervical root disorders

0.00

0.40

0.0

1.0

—

254.50

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

240.60

—

Lung transplant status

0.00

0.40

0.0

1.0

—

249.00

—

Lung transplantation

0.00

0.40

0.0

1.0

—

249.00

—

Malignant neoplasm of parotid gland

0.00

0.40

0.0

1.0

—

240.75

—

Blindness, monocular

0.00

0.40

0.0

1.0

—

275.70

—

Acute mastoiditis

0.00

0.40

0.0

1.0

—

277.38

—

Other injuries of lower limb, level unspecified

0.00

0.40

0.0

1.0

—

273.25

—

Other and unspecified acquired haemolytic anaemias

0.00

0.40

0.0

1.0

—

230.70

—

Benign neoplasm: Short bones of lower limb

0.00

0.40

0.0

1.0

—

296.45

—

Striae atrophicae

0.00

0.40

0.0

1.0

—

305.00

—

Migraine without aura, drug-induced

0.00

0.40

0.0

1.0

—

228.67

—

Use of cabergoline

0.00

0.40

0.0

1.0

—

269.44

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

238

0.80

0.40

1.1

1.0

208.07

311.80

ng/l

2.31

163

Assault by sharp object

0.00

0.40

0.0

1.0

—

221.83

—

Acute bronchitis

942

0.90

0.40

1.0

238.68

331.96

ng/l

4.05

636

Complications of labour and delivery

137

826

0.92

0.39

1.0

389.59

358.78

ng/l

0.19

100

605

Congenital malformations of great arteries

0.00

0.39

0.0

1.0

—

268.11

—

Preparatory care for dialysis

101

0.69

0.39

1.0

435.29

306.78

ng/l

—

Ectopic pregnancy

368

0.84

0.39

1.0

276.60

432.67

ng/l

0.91

274

Other medical care

122

1192

0.92

0.39

1.0

704.03

331.51

ng/l

0.57

796

Unspecified event, undetermined intent

1.43

0.39

1.0

254.60

256.73

ng/l

—

Granulomatous disorders of skin and subcutaneous tissue

1.43

0.39

1.0

260.80

311.32

ng/l

—

Complications peculiar to reattachment and amputation

0.00

0.39

0.0

1.0

—

263.89

—

Leiomyosarcoma

0.00

0.39

0.0

1.0

—

292.67

—

Polyarteritis nodosa

0.00

0.39

0.0

1.0

—

288.10

—

Malignant neoplasm of eye and adnexa

0.00

0.39

0.0

1.0

—

284.14

—

Use of entacapone

0.00

0.39

0.0

1.0

—

270.20

—

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.0

—

260.36

—

Ovarian cyst

425

1.11

0.39

1.0

753.52

337.38

ng/l

0.47

302

Nonalcoholic fatty liver disease

226

0.80

0.39

1.0

227.92

323.81

ng/l

0.93

158

Pain and other conditions associated with female genital organs and menstrual cycle

290

1.17

0.39

1.1

1.0

290.50

334.71

ng/l

0.57

214

Other noninflammatory disorders of uterus, except cervix

399

0.88

0.38

1.0

345.62

341.54

ng/l

0.04

281

Other infective otitis externa

133

1.28

0.38

1.0

294.25

309.85

ng/l

0.12

Nail disorders

160

1.25

0.38

1.1

1.0

239.21

290.66

ng/l

0.60

107

Bronchitis

294

1951

0.95

0.38

1.0

259.82

344.47

ng/l

3.41

210

1380

Preterm labour and delivery

532

1.13

0.38

1.0

298.49

378.87

ng/l

0.57

394

Noninflammatory disorders of female genital tract

425

0.90

0.38

1.0

309.57

337.38

ng/l

0.56

302

ILD medications: prednisolone, methylprednisolone, prednisone

306

1802

0.95

0.38

1.0

293.71

331.13

ng/l

0.89

217

1289

Endometriosis ASRM stages 3,4

410

1.15

0.38

1.0

346.27

352.14

ng/l

0.04

290

Benign neoplasm: Adrenal gland

215

1.21

0.38

1.0

305.61

320.67

ng/l

0.13

138

Cholecystectomy

197

1809

0.94

0.38

1.0

323.19

342.42

ng/l

0.29

128

1284

Acute appendicitis

177

1767

0.94

0.37

1.1

1.0

282.36

330.94

ng/l

1.23

137

1279

Disorders of tooth development and eruption

209

0.81

0.37

1.0

245.60

359.51

ng/l

—

155

Seronegative rheumatoid arthritis

301

0.83

0.37

1.0

362.94

339.72

ng/l

0.16

213

Combinations of oral blood glucose lowering drugs

886

1.10

0.37

1.1

1.0

288.18

334.65

ng/l

0.64

625

Traumatic amputation of wrist and hand

107

1.31

0.37

1.0

356.25

302.22

ng/l

—

Asthma/COPD (KELA code 203)

284

1847

1.05

0.37

1.0

296.77

339.75

ng/l

1.00

198

1315

Arthropathies

250

1196

1.06

0.37

1.0

293.45

311.50

ng/l

0.60

182

859

Herpesviral [herpes simplex] infections

493

0.87

0.37

1.0

255.78

324.45

ng/l

1.92

349

Asthma-related pneumonia

904

1.09

0.36

1.0

281.89

333.26

ng/l

1.41

609

Other arrhythmias

191

1534

0.94

0.36

1.0

322.60

346.72

ng/l

0.36

131

1106

Glucosamine medication

168

1253

1.07

0.36

1.0

320.68

335.21

ng/l

0.24

112

868

Anomalies of dental arch relationship, including avohilmo

290

0.84

0.36

1.0

287.78

315.77

ng/l

0.30

204

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

193

1836

0.94

0.36

1.0

279.07

345.75

ng/l

1.78

150

1268

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

118

686

1.09

0.36

1.0

296.37

334.82

ng/l

1.03

525

Single spontaneous delivery

453

1.10

0.36

1.0

327.49

339.17

ng/l

0.13

310

Complications predominantly related to the puerperium

431

1.14

0.36

1.0

302.87

419.19

ng/l

0.72

315

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.65

0.36

1.0

471.60

378.80

ng/l

—

Crohn disease

263

1.18

0.35

1.0

323.16

321.75

ng/l

0.01

185

Pleural plaque with presence of asbestos

201

0.79

0.35

1.0

217.18

324.92

ng/l

1.10

126

Non-allergic asthma (mode), excluding more controls

493

1.13

0.35

1.0

311.49

361.96

ng/l

0.66

327

Other female pelvic inflammatory diseases

338

1.15

0.35

1.0

304.62

369.97

ng/l

0.75

234

Other and unspecified injuries of lower leg

135

1.26

0.35

1.1

1.0

260.17

303.98

ng/l

0.29

Other disorders of bone density and structure

1.40

0.35

1.2

1.0

383.00

240.81

ng/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

357

1.15

0.35

1.0

345.42

313.29

ng/l

0.26

262

Congenital malformations of heart and great arteries

226

0.81

0.34

1.0

261.64

309.42

ng/l

0.61

154

Presence of cardiac and vascular implants and grafts

136

1086

0.93

0.34

1.0

280.71

325.42

ng/l

1.79

100

730

Ulcerative colitis, NAS

298

0.84

0.34

1.0

304.47

328.38

ng/l

0.24

213

Obstructed labour due to maternal pelvic abnormality

348

1.15

0.34

1.0

512.97

418.04

ng/l

0.21

255

Other diseases of intestine

395

1.14

0.34

1.0

288.84

322.25

ng/l

0.49

273

Lichen ruber planus, wide definition including periferal and oral lichen planus

594

1.11

0.34

1.0

316.65

336.43

ng/l

0.21

424

Superficial injury of ankle and foot

200

0.80

0.34

1.1

1.0

298.90

314.40

ng/l

—

135

Delivery

453

1.10

0.34

1.0

324.61

339.17

ng/l

0.17

310

Asthma, hospital admission 2, infections

157

1439

1.07

0.34

1.0

286.09

344.29

ng/l

0.96

103

998

Asthma-related infections

157

1439

1.07

0.34

1.0

286.09

344.29

ng/l

0.96

103

998

Chronic sinusitis

121

1121

1.08

0.34

1.0

299.03

315.00

ng/l

0.31

795

Other disorders of prostate

1.34

0.34

1.0

216.17

296.04

ng/l

—

Allergic purpura

1.33

0.33

1.0

250.00

247.37

ng/l

—

Asthma, hospital admissions 3, pneumonia

909

1.09

0.33

1.0

281.89

334.09

ng/l

1.45

613

Asthma-related pneumonia or sepsis

909

1.09

0.33

1.0

281.89

334.09

ng/l

1.45

613

Dermatophytosis

176

1654

1.06

0.33

1.0

279.71

337.79

ng/l

1.41

123

1180

Uterine polyps

221

0.81

0.33

1.0

270.08

339.76

ng/l

1.01

161

Diseases of arteries, arterioles and capillaries (FINNGEN)

528

0.90

0.33

1.0

304.42

352.29

ng/l

0.99

401

Other diseases of anus and rectum

795

1.09

0.33

1.0

295.82

336.27

ng/l

0.80

548

Vitamin B12 deficiency anaemia

256

1.17

0.33

1.1

1.0

246.37

315.69

ng/l

0.93

160

Pregnancy, childbirth and the puerperium

275

1.12

0.33

1.0

354.60

308.76

ng/l

0.49

176

Otitis externa

501

1.12

0.33

1.0

290.00

320.12

ng/l

0.42

356

Thyroiditis, ILD-related definition

210

1.19

0.32

1.0

330.47

332.75

ng/l

0.01

150

Atopic dermatitis

135

1032

1.07

0.32

1.0

281.99

343.48

ng/l

0.89

105

748

Other and unspecified visual disturbances

238

1.18

0.32

1.0

514.29

323.44

ng/l

0.38

157

Obesity and other hyperalimentation

155

1590

0.94

0.32

1.0

236.79

333.98

ng/l

3.47

114

1143

Varicose veins of other sites

155

1.23

0.32

1.0

231.77

297.12

ng/l

0.80

108

Stenosis and insufficiency of lacrimal passages

201

1.20

0.32

1.1

1.0

301.92

327.76

ng/l

0.37

132

Conjunctivitis (acute, non atopic)

576

1.11

0.32

1.0

290.93

330.78

ng/l

0.48

407

Other acute lower respiratory infections

117

1198

0.93

0.31

1.0

233.27

320.85

ng/l

5.16

830

Other inflammation of eyelid

304

1.15

0.31

1.0

281.96

329.56

ng/l

1.08

206

Benign neoplasm: Ascending colon

389

1.13

0.31

1.0

275.32

330.31

ng/l

0.96

266

Hypokalaemia

295

1.15

0.31

1.1

1.0

1293.36

353.06

ng/l

0.43

199

Other disorders of skin and subcutaneous tissue

216

1821

1.05

0.31

1.0

304.80

346.33

ng/l

0.87

143

1283

Benign neoplasm: Tongue

1.32

0.31

1.1

1.0

169.00

318.73

ng/l

—

Rheumatoid arthritis

838

0.92

0.30

1.0

332.45

326.64

ng/l

0.08

583

Lesion of ulnar nerve

352

1.14

0.30

1.0

295.19

307.65

ng/l

0.08

253

Triptan medication for migraine, min. 3 purchases

109

895

0.93

0.30

1.0

269.07

354.31

ng/l

1.28

672

Spirochaetal infections, other/unspecified

221

1.18

0.30

1.1

1.0

268.74

325.93

ng/l

0.88

149

Chalazion

249

1.17

0.30

1.1

1.0

334.57

325.73

ng/l

0.05

172

Heartburn

249

1.17

0.30

1.1

1.0

271.29

322.34

ng/l

1.11

175

Short Achilles tendon (acquired)

1.30

0.30

1.3

1.0

278.29

342.09

ng/l

—

LSIL lesion of the cervix uteri, vagina or vulva

184

1.20

0.30

1.0

264.57

337.92

ng/l

1.17

138

Azathioprine

315

1.14

0.30

1.0

341.86

326.25

ng/l

0.10

226

All dysplastic lesions of the cervix uteri

301

0.86

0.30

1.0

267.61

332.89

ng/l

1.12

228

Other arthritis (FG)

838

0.92

0.29

1.0

365.04

362.21

ng/l

0.01

585

Benign neoplasm of ovary

401

1.12

0.29

1.0

280.91

361.39

ng/l

1.54

282

Hypertrophy of breast

335

1.13

0.29

1.0

319.43

345.24

ng/l

0.21

245

Other otitis externa (chronic)

139

1.22

0.29

1.0

200.60

294.92

ng/l

—

Injuries involving multiple body regions

1.23

0.29

1.1

1.0

367.29

274.72

ng/l

—

Other and unspecified dermatitis

149

1404

1.06

0.29

1.0

268.12

344.04

ng/l

1.76

101

987

Unspecified misadventure during surgical and medical care

130

1.23

0.28

1.0

233.73

296.89

ng/l

0.76

Obesity

155

1583

0.94

0.28

1.0

236.79

333.91

ng/l

3.46

114

1141

Major coronary heart disease event excluding revascularizations

203

1422

0.95

0.28

1.0

285.53

328.19

ng/l

1.56

137

1014

Infections with a predominantly sexual mode of transmission

468

1.11

0.28

1.0

276.05

326.21

ng/l

1.14

336

Impacted cerumen

251

1.16

0.28

1.0

201.31

307.68

ng/l

2.77

167

Internal derangement of knee

111

1032

1.07

0.28

1.0

263.72

308.97

ng/l

1.44

741

Haemorrhoids and perianal venous thrombosis

900

1.08

0.27

1.0

305.82

331.19

ng/l

0.35

617

Benign neoplasm: Rectum, anus and anal canal

594

1.09

0.27

1.0

315.27

328.71

ng/l

0.21

397

Endometriosis ASRM stages 1,2

280

1.14

0.27

1.0

352.24

358.84

ng/l

0.04

202

Peritonsillar abscess

417

0.89

0.27

1.0

255.46

301.16

ng/l

0.85

302

HSIL lesion of the cervix uteri, vagina or vulva

226

0.84

0.27

1.0

262.08

331.91

ng/l

1.13

168

Other disorders of skin and subcutaneous tissue, not elsewhere classified

343

0.87

0.27

1.1

1.0

258.95

330.98

ng/l

1.25

236

ILD medications: azathioprine

318

1.13

0.27

1.0

341.86

326.96

ng/l

0.09

223

Coeliac disease

252

1.15

0.27

1.0

332.04

323.61

ng/l

0.04

173

Congenital malformations, deformations and chromosomal abnormalities

133

1192

1.06

0.27

1.0

292.46

333.73

ng/l

0.57

863

Pregnancy hypertension

710

0.92

0.27

1.1

1.0

844.40

320.68

ng/l

0.54

530

Delivery, wide proxy

335

1.09

0.27

1.0

346.14

322.47

ng/l

0.25

214

Excessive, frequent and irregular menstruation

425

1.08

0.26

1.0

383.88

337.38

ng/l

0.22

302

Vascular disorders of the intestines

159

1.20

0.26

1.0

252.63

297.34

ng/l

—

101

Phlebitis and thrombophlebitis (not including DVT)

594

0.91

0.26

1.0

281.33

322.20

ng/l

0.75

425

Major coronary heart disease event

300

1740

1.04

0.26

1.0

286.61

343.79

ng/l

1.60

196

1268

Squamous cell neoplasms and carcinomas of the skin

214

0.84

0.26

1.0

255.22

354.34

ng/l

—

128

Other epidermal thickening

1.28

0.26

1.1

1.0

201.17

306.94

ng/l

—

Certain disorders involving the immune mechanism

462

1.10

0.26

1.0

282.51

321.90

ng/l

0.85

326

Acute upper respiratory infections of multiple and unspecified sites

187

1455

0.95

0.26

1.0

263.21

340.31

ng/l

1.89

140

1033

Thyrotoxicosis

593

0.91

0.26

1.0

272.18

339.92

ng/l

1.03

412

Benign lipomatous neoplasm

799

1.08

0.26

1.0

326.21

328.90

ng/l

0.03

562

Other hearing loss

692

0.92

0.26

1.0

317.30

341.66

ng/l

0.34

460

Other, unspecified and serous retinal detachments

1.20

0.25

1.1

1.0

239.78

252.35

ng/l

—

Unspecified jaundice

105

1.24

0.24

1.0

338.50

299.37

ng/l

—

Benign neoplasm of other and ill-defined parts of digestive system

483

1.10

0.24

1.1

1.0

329.18

337.83

ng/l

0.07

336

Bacterial pneumonia (organism specified)

112

1079

0.94

0.24

1.0

236.97

341.85

ng/l

7.88

736

Other anaemias

115

1160

0.94

0.24

1.0

331.42

343.76

ng/l

0.17

767

Spondyloarthritis

378

1.11

0.24

1.0

259.85

319.10

ng/l

1.59

273

Plantar fascial fibromatosis

217

1.15

0.24

1.0

281.56

356.02

ng/l

1.38

147

Artrosis, including avohilmo

257

1351

1.04

0.24

1.0

294.83

341.10

ng/l

0.85

182

984

Carcinoma in situ of breast, intraductal

212

0.85

0.24

1.0

352.54

372.06

ng/l

0.13

148

Coagulation defects, purpura and other haemorrhagic conditions

433

0.90

0.23

1.0

293.45

324.96

ng/l

0.33

295

Trigger finger

360

1.11

0.23

1.0

269.06

357.70

ng/l

1.66

254

Excessive attrition of teeth

148

1407

1.05

0.23

1.0

280.53

336.74

ng/l

1.16

110

1019

Disorders of gallbladder, biliary tract and pancreas

298

1946

0.97

0.23

1.0

300.72

334.95

ng/l

0.82

196

1396

Iron deficiency anaemia secondary to blood loss (chronic)

401

0.90

0.23

1.0

349.85

327.62

ng/l

0.16

266

Cholecystitis

359

0.89

0.23

1.0

341.35

333.08

ng/l

0.08

247

Diabetic nephropathy

337

1.11

0.23

1.0

348.20

274.58

ng/l

0.88

224

Diabetic maculopathy, excluding more controls

237

1.14

0.23

1.0

220.94

309.45

ng/l

2.02

161

Other heart diseases, wide

278

1638

1.04

0.23

1.0

295.39

338.68

ng/l

0.95

198

1189

Thyrotoxicosis, other and/or unspecified

453

0.90

0.23

1.0

256.13

352.55

ng/l

1.36

326

Benign neoplasm: Vulva

1.28

0.23

1.0

526.20

353.08

ng/l

—

Chronic pancreatitis

348

0.89

0.22

1.0

191.74

317.75

ng/l

5.26

253

Other metabolic disorders

266

1.13

0.22

1.0

295.91

350.98

ng/l

0.41

183

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.25

0.22

1.0

244.00

458.54

ng/l

—

Non-follicular lymphoma

263

0.87

0.22

1.0

337.89

314.55

ng/l

0.21

175

Other and unspecified anaemias

115

1157

0.95

0.21

1.0

331.42

344.03

ng/l

0.17

765

Macular pucker

472

0.91

0.21

1.0

313.13

326.92

ng/l

0.16

313

Endometriosis of ovary

328

0.89

0.21

1.0

327.71

327.75

ng/l

0.00

236

Other nonautoimmune haemolytic anaemias

0.00

0.21

0.0

1.0

—

297.00

—

Cytomegaloviral hepatitis

0.00

0.21

0.0

1.0

—

262.80

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.0

—

269.17

—

Toxic colitis

0.00

0.21

0.0

1.0

—

293.00

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.21

0.0

1.0

—

289.17

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.0

—

267.60

—

Pneumonia due to Haemophilus influenzae

0.00

0.21

0.0

1.0

—

293.60

—

Lupus nephritis

0.00

0.21

0.0

1.0

—

251.00

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.0

—

245.60

—

Systemic sclerosis, icd10

1.19

0.21

1.0

422.20

342.00

ng/l

—

Listeriosis

0.00

0.21

0.0

1.0

—

280.80

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.0

—

261.60

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.21

0.0

1.0

—

247.80

—

Other congenital malformations of urinary system

0.00

0.21

0.0

1.0

—

275.00

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.21

0.0

1.0

—

256.60

—

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

1.0

—

262.80

—

Other specified transport accidents

0.00

0.21

0.0

1.0

—

305.80

—

Other superficial injuries of ankle and foot

0.00

0.21

0.0

1.0

—

290.17

—

Clubfoot

0.00

0.21

0.0

1.0

—

245.60

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

271.50

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.21

0.0

1.0

—

306.67

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.0

—

259.43

—

Allergic bronchopulmonary aspergillosis (ABPA)

0.00

0.21

0.0

1.0

—

272.60

—

Nezelof syndrome

0.00

0.21

0.0

1.0

—

245.29

—

Congenital cataract

0.00

0.21

0.0

1.0

—

293.71

—

Congenital malformations of oesophagus

0.00

0.21

0.0

1.0

—

228.17

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

250.83

—

Other dermatomyositis

0.00

0.21

0.0

1.0

—

293.71

—

Severe visual impairment, binocular

0.00

0.21

0.0

1.0

—

301.00

—

Melanocytic naevi of ear and external auricular canal

0.00

0.21

0.0

1.0

—

253.43

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

290.71

—

Dacryoadenitis

0.00

0.21

0.0

1.0

—

318.29

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.21

0.0

1.0

—

236.86

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.21

0.0

1.0

—

212.17

—

Enterobiasis

0.00

0.21

0.0

1.0

—

253.71

—

Congenital malformations, deformations and chromosomal abnormalities

152

1337

1.05

0.21

1.0

291.84

331.31

ng/l

0.61

110

958

Calcific tendinitis of shoulder

126

1.19

0.21

1.0

294.70

354.98

ng/l

—

Other disorders of optic [2nd] nerve and visual pathways

126

1.19

0.21

1.0

343.80

303.47

ng/l

—

Left side

0.00

0.21

0.0

1.0

—

244.38

—

0.00

0.21

0.0

1.0

—

289.87

—

Other/unspecified mastoiditis and related conditions

0.00

0.21

0.0

1.0

—

275.00

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

289.88

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

245.00

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.0

—

295.88

—

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.0

—

247.71

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.0

—

273.00

—

Drug-induced systemic lupus erythematosus

0.00

0.21

0.0

1.0

—

276.57

—

Acute inflammation of orbit

0.00

0.21

0.0

1.0

—

250.50

—

Acute myringitis

0.00

0.21

0.0

1.0

—

259.14

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.21

0.0

1.0

—

280.88

—

Mesial bite

0.00

0.21

0.0

1.0

—

264.63

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.21

0.0

1.0

—

238.63

—

Chronic laryngitis and laryngotracheitis

373

1.10

0.21

1.0

347.69

321.55

ng/l

0.23

262

Undetermined asthma, excluding more controls

324

0.89

0.20

1.0

370.14

359.75

ng/l

0.05

215

Undetermined asthma

324

0.89

0.20

1.0

370.14

355.56

ng/l

0.07

217

Rheumatoid lung disease

0.00

0.20

0.0

1.0

—

260.89

—

Carcinoma in situ of endometrium

0.00

0.20

0.0

1.0

—

225.56

—

Blindness or visual impairment, binocular

0.00

0.20

0.0

1.0

—

283.25

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.20

0.0

1.0

—

228.33

—

Benign neoplasm: Retina

0.00

0.20

0.0

1.0

—

295.88

—

Reiter disease

0.00

0.20

0.0

1.0

—

274.14

—

Exposure to other and unspecified forces of nature

0.00

0.20

0.0

1.0

—

278.33

—

Serous carcinoma of ovary

0.00

0.20

0.0

1.0

—

295.50

—

Carcinoma in situ of breast, lobular

0.00

0.20

0.0

1.0

—

244.33

—

Codeine or tramadol medication

341

1810

1.03

0.20

1.0

377.48

327.27

ng/l

0.19

243

1277

Benign neoplasm of major salivary glands

261

0.88

0.20

1.0

329.33

321.93

ng/l

0.04

175

Septicaemia

124

1104

1.05

0.20

1.0

291.78

344.55

ng/l

1.30

751

Other disorders of iris and ciliary body

1.20

0.19

1.0

291.50

286.31

ng/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.20

0.19

1.0

324.83

250.05

ng/l

—

Other and unspecified iron deficiency

860

0.94

0.19

1.0

309.35

335.55

ng/l

0.38

581

Vestibular neuronitis

231

1.13

0.19

1.0

253.33

326.76

ng/l

0.95

151

Benign leiomyoma with endometriosis

365

1.10

0.19

1.0

370.32

352.03

ng/l

0.12

252

Other or unspecified ileus, impaction or obstruction

481

1.08

0.19

1.0

279.65

324.60

ng/l

1.02

330

Acne

1.15

0.19

1.2

1.0

201.67

206.12

ng/l

—

Other peripheral vertigo

228

0.88

0.19

1.1

1.0

258.40

319.84

ng/l

1.02

147

Otitis media, unspecified

126

1.17

0.18

1.0

325.91

276.47

ng/l

0.34

Striking against or struck by other objects

695

1.06

0.18

1.0

287.50

302.59

ng/l

0.30

493

Retinal breaks without detachment

463

1.08

0.18

1.0

376.97

314.56

ng/l

0.86

319

5-aminosalicylic acid

463

1.08

0.18

1.0

317.15

323.60

ng/l

0.05

330

Other disorders of kidney and ureter

338

1.10

0.18

1.0

289.38

319.53

ng/l

0.34

226

All dysplastic lesions of the cervix uteri, vagina or vulva

398

0.92

0.18

1.0

242.69

423.30

ng/l

1.31

297

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

306

1904

1.03

0.18

1.0

338.08

331.67

ng/l

0.07

206

1371

Ulcerative colitis

551

1.07

0.18

1.0

270.44

323.56

ng/l

1.64

389

Contact with machinery

300

0.90

0.18

1.0

296.42

285.46

ng/l

0.09

215

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

319

1.10

0.18

1.0

304.37

316.79

ng/l

0.15

229

Primary coxarthrosis, bilateral

867

0.95

0.17

1.0

254.50

332.61

ng/l

3.92

585

Disturbances of skin sensation

600

1.07

0.17

1.0

274.67

317.74

ng/l

0.97

431

Unspecified acute lower respiratory infection

329

1.09

0.17

1.0

217.16

312.94

ng/l

2.96

230

Pregnancy with abortive outcome

145

789

0.96

0.17

1.0

364.50

376.51

ng/l

0.09

101

568

Conductive hearing loss, unspecified

176

1.14

0.17

1.0

221.36

293.41

ng/l

1.38

121

Degeneration of macula and posterior pole

143

1185

0.96

0.17

1.0

326.21

336.80

ng/l

0.18

786

Other spirochaetal diseases

835

1.05

0.17

1.0

311.98

328.40

ng/l

0.28

586

Zoster [herpes zoster]

465

1.08

0.17

1.1

1.0

237.44

338.73

ng/l

3.75

316

Lichen planus

349

1.09

0.17

1.1

1.0

312.69

336.81

ng/l

0.23

238

Blepharochalasis

884

1.05

0.17

1.0

304.35

334.19

ng/l

0.44

598

Neoplasms

207

1060

1.03

0.17

1.0

297.72

306.05

ng/l

0.17

151

744

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

330

0.91

0.17

1.0

331.35

328.28

ng/l

0.02

225

Persons encountering health services in circumstances related to reproduction

144

1009

0.96

0.16

1.0

311.70

345.06

ng/l

0.35

107

764

Other bacterial intestinal infections

427

1.08

0.16

1.0

277.02

323.19

ng/l

1.15

287

Other specified/unspecified arthritis

721

0.94

0.16

1.0

371.00

316.08

ng/l

0.25

501

Thiazolidinediones

340

1.09

0.16

1.1

1.0

230.10

337.27

ng/l

3.69

228

Rosacea

244

1.11

0.16

1.0

310.26

336.16

ng/l

0.17

168

Viral infections characterized by skin and mucous membrane lesions

232

2042

0.97

0.16

1.0

265.43

337.57

ng/l

2.98

162

1460

Calculus of kidney and ureter

833

0.95

0.16

1.0

293.93

315.03

ng/l

0.28

584

Oral corticosteroids

320

1850

1.03

0.16

1.0

324.52

330.61

ng/l

0.07

227

1318

Other disorders of patella

370

0.92

0.16

1.0

333.52

315.94

ng/l

0.15

271

Visual field defects

193

0.88

0.15

1.1

1.0

766.25

305.39

ng/l

0.58

127

Spirochaetal infections, other/unspecified

828

1.05

0.15

1.0

307.90

328.08

ng/l

0.36

582

Endometriosis of pelvic peritoneum

279

1.09

0.15

1.0

352.24

334.56

ng/l

0.13

204

Chondropathies

322

1.09

0.15

1.0

268.62

327.98

ng/l

1.29

230

Other necrotizing vasculopathies

178

1.12

0.15

1.0

326.08

325.60

ng/l

0.00

112

Vitreous haemorrhage

255

0.90

0.15

1.0

318.33

311.07

ng/l

0.04

172

Zoster [herpes zoster]

142

1449

0.96

0.15

1.0

263.71

356.15

ng/l

2.59

100

1006

Other complications of surgical and medical care, not elsewhere classified

226

1.11

0.15

1.0

304.50

326.24

ng/l

0.14

144

Other maternal disorders predominantly related to pregnancy

121

790

0.96

0.15

1.0

307.29

375.29

ng/l

0.77

592

Chronic nephritic syndrome

1.11

0.15

1.2

1.0

409.89

274.52

ng/l

—

Percutaneous Coronary Intervention

277

1654

1.03

0.15

1.0

296.43

346.20

ng/l

1.14

172

1208

Nontoxic goitre/thyroid nodule

789

0.95

0.14

1.0

324.38

330.22

ng/l

0.06

543

All chronic kidney diseases

149

1261

0.97

0.14

1.0

300.69

329.64

ng/l

0.75

110

848

Perforation of tympanic membrane

217

1.11

0.14

1.0

290.62

326.08

ng/l

0.37

143

Autoimmune diseases related-to ILD

232

2038

0.97

0.14

1.0

297.14

334.61

ng/l

0.82

158

1461

Benign neoplasm: Skin of eyelid, including canthus

401

1.07

0.14

1.1

1.0

314.37

324.09

ng/l

0.08

275

Presence of other functional implants

195

1393

0.97

0.14

1.0

312.26

358.96

ng/l

0.73

136

962

Other viral diseases, not elsewhere classified

342

1.08

0.14

1.0

300.69

311.34

ng/l

0.07

240

Diabetic maculopathy

232

1.10

0.14

1.0

220.94

278.41

ng/l

1.11

170

Other nutritional deficiencies

168

1631

0.97

0.14

1.0

234.00

334.18

ng/l

3.86

122

1172

Unspecified kidney failure

237

1.10

0.14

1.0

243.05

313.94

ng/l

1.31

151

Lymphoid leukaemia

128

0.86

0.13

1.2

1.0

242.40

309.67

ng/l

—

Non-allergic asthma

189

1.11

0.13

1.0

363.25

335.87

ng/l

0.15

120

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

170

1.12

0.13

1.1

1.0

295.54

307.50

ng/l

0.10

110

Glomerular disorders in diseases classified elsewhere

284

0.92

0.13

1.0

355.52

301.87

ng/l

0.61

194

Obesity due to excess calories

120

1157

1.04

0.13

1.0

229.69

343.61

ng/l

2.93

829

Ulcerative colitis (strict definition, all Crohn cases excluded)

286

1.08

0.13

1.0

294.35

321.27

ng/l

0.38

200

Pre-eclampsia

335

0.93

0.13

1.1

1.0

1608.57

349.41

ng/l

0.50

247

Acute pancreatitis (for exclusion)

540

0.94

0.13

1.0

311.47

322.74

ng/l

0.13

374

Contraceptive management

686

0.96

0.12

1.0

312.90

350.89

ng/l

0.29

536

Diabetic retinopathy, strict definition

305

1.07

0.12

1.0

295.93

271.79

ng/l

0.24

218

102

975

1.04

0.12

1.0

285.63

356.97

ng/l

0.77

684

Postmenopausal atrophic vaginitis

416

0.95

0.12

1.0

302.18

339.78

ng/l

0.84

298

Other disorders of the genitourinary system

317

1.07

0.12

1.0

472.48

355.66

ng/l

0.92

212

Atrophic disorders of skin

323

0.93

0.11

1.0

316.39

341.91

ng/l

0.18

224

Dermatitis

177

1718

1.03

0.11

1.0

268.35

345.11

ng/l

2.37

121

1216

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

172

1742

0.97

0.11

1.0

302.87

322.58

ng/l

0.37

122

1215

Ethmoidectomy

312

0.93

0.11

1.0

286.50

327.02

ng/l

0.57

221

Acute pancreatitis

537

0.95

0.11

1.0

311.47

321.48

ng/l

0.11

384

Osteonecrosis

153

1.11

0.11

1.0

329.64

323.09

ng/l

0.04

Inguinal hernia, bilateral

289

1.07

0.11

1.0

267.35

307.86

ng/l

0.48

194

Ulcerative colitis (strict definition, require KELA)

328

1.07

0.11

1.0

304.37

315.68

ng/l

0.14

236

Retained placenta and membranes, without haemorrhage

229

0.92

0.10

1.1

1.0

454.53

333.51

ng/l

0.89

166

Medical abortion

141

787

0.97

0.10

1.0

369.87

376.51

ng/l

0.05

100

568

Other skin changes

485

0.95

0.10

1.0

299.19

333.16

ng/l

0.65

333

Emergency coronary revascularization (for ACS)

299

1784

1.02

0.10

1.0

295.02

342.15

ng/l

1.16

187

1299

Deep bite

146

0.90

0.10

1.0

307.00

293.41

ng/l

—

Ptosis of eyelid

290

1.07

0.10

1.1

1.0

200.77

325.81

ng/l

5.36

194

Systemic sclerosis (FG)

1.14

0.10

1.0

422.20

365.96

ng/l

—

Vasomotor rhinitis (mode)

164

1.10

0.09

1.0

255.08

312.08

ng/l

0.74

109

Other specific arthropathies, wide

1.09

0.09

1.0

255.80

318.84

ng/l

—

Systemic sclerosis

1.09

0.09

1.0

422.20

348.79

ng/l

—

Aggressive periodontitis

1.06

0.09

1.2

1.0

208.60

274.59

ng/l

—

Other embolism and thrombosis

330

1.06

0.09

1.1

1.0

349.43

310.06

ng/l

0.42

229

Other disorders of eyelid

142

1318

1.03

0.09

1.0

288.55

361.19

ng/l

1.29

908

Gestational [pregnancy-induced] hypertension

339

1.06

0.09

1.1

1.0

311.96

344.75

ng/l

0.33

253

Other diseases of blood and blood-forming organs

176

0.91

0.09

1.0

302.55

298.24

ng/l

0.02

111

Obesity, other/unspecified

747

0.96

0.09

1.0

228.51

367.28

ng/l

2.00

543

Coronary revascularization (ANGIO or CABG)

275

1654

1.02

0.09

1.0

295.22

346.20

ng/l

1.19

175

1208

Diabetes mellitus in pregnancy

172

0.93

0.09

1.0

258.61

293.98

ng/l

0.50

138

Otosclerosis

186

0.91

0.09

1.0

553.40

316.85

ng/l

—

120

Coxarthrosis, primary

197

1701

0.98

0.09

1.0

345.48

346.94

ng/l

0.01

124

1191

Salpingitis and oophoritis

421

0.95

0.09

1.1

1.0

327.28

432.31

ng/l

0.52

302

Reactive arthropathies

196

0.92

0.09

1.0

307.08

336.94

ng/l

0.17

141

LSIL lesion of the cervix uteri

126

1.11

0.09

1.0

287.22

325.10

ng/l

—

Lichen sclerosus et atrophicus

233

1.07

0.09

1.0

314.43

344.57

ng/l

0.17

161

Pacemaker

902

1.03

0.09

1.0

310.13

345.22

ng/l

0.71

581

Other abnormal uterine and vaginal bleeding

389

0.96

0.08

1.0

284.40

342.61

ng/l

1.51

273

Entropion and trichiasis of eyelid

206

0.92

0.08

1.1

1.0

276.55

313.93

ng/l

0.28

125

Other specified/unspecified hearing loss

204

1.08

0.08

1.1

1.0

274.41

303.41

ng/l

0.37

135

Nontoxic multinodular goitre

512

0.96

0.08

1.0

337.57

356.79

ng/l

0.13

354

Inguinal or femoral hernia, bilateral

292

1.06

0.08

1.0

267.35

308.59

ng/l

0.50

195

Acute appendicitis, no complications

137

1396

0.98

0.08

1.0

269.79

327.97

ng/l

1.25

107

1015

Other and unspecified disease of Bartholin gland

1.05

0.08

1.0

289.17

340.71

ng/l

—

Acute sinusitis

123

1110

1.03

0.08

1.0

273.82

346.57

ng/l

1.08

790

Lyme disease

824

1.03

0.08

1.0

305.65

328.87

ng/l

0.42

579

Benign neoplasm of mouth and pharynx

263

1.07

0.08

1.1

1.0

205.50

321.42

ng/l

5.42

175

345

1757

1.01

0.08

1.0

284.24

350.27

ng/l

1.94

241

1245

Viral infections characterized by skin and mucous membrane lesions

102

1047

0.97

0.08

1.0

245.95

320.00

ng/l

3.83

734

Diseases of salivary glands

795

0.97

0.08

1.0

304.21

327.11

ng/l

0.44

560

Coronary atherosclerosis

238

1480

1.02

0.08

1.0

290.08

353.29

ng/l

1.43

157

1064

Triptan medication for migraine, single purchase ok

191

1318

0.98

0.08

1.0

284.45

339.96

ng/l

1.06

137

977

Migraine, single triptan purchase ok & required. ICD-code if available is included

191

1318

0.98

0.08

1.0

284.45

339.96

ng/l

1.06

137

977

Pediculosis, acariasis and other infestations

283

1.06

0.08

1.1

1.0

276.71

308.14

ng/l

0.31

197

Other specified/unspecified dorsopathies

1.05

0.08

1.1

1.0

283.00

317.98

ng/l

—

Other specified and unspecified disorders of eye and adnexa

1.04

0.08

1.0

413.57

285.63

ng/l

—

Benign neoplasm of bone and articular cartilage

164

0.91

0.08

1.0

346.60

278.42

ng/l

—

104

Atrial fibrillation and flutter

618

1.03

0.08

1.0

352.68

344.66

ng/l

0.08

473

Benign neoplasm: Pancreas

0.83

0.07

1.0

211.50

335.28

ng/l

—

Use of rasagiline

0.82

0.07

1.2

1.0

242.33

312.57

ng/l

—

Other/unspecified synovitis and tenosynovitis

264

1.06

0.07

1.0

317.77

358.82

ng/l

0.34

187

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

137

1.10

0.07

1.1

1.0

283.56

338.36

ng/l

—

Glomerulonephritis

225

0.93

0.07

1.1

1.0

333.13

303.33

ng/l

0.18

151

Infective dermatitis

276

0.94

0.07

1.0

280.88

323.31

ng/l

0.41

190

Spontaneous abortion

678

0.97

0.07

1.0

302.17

378.60

ng/l

0.73

506

Postprocedural endocrine and metabolic disorders, not elsewhere classified

245

1.06

0.07

1.0

259.89

346.52

ng/l

1.06

168

Tuberculosis, IBD comorbidity

157

1.08

0.07

1.1

1.0

249.30

303.44

ng/l

—

Any death

213

1549

0.98

0.07

1.0

553.69

310.29

ng/l

0.81

155

1074

Disorders of vitreous body and globe

170

1604

1.02

0.07

1.0

326.45

349.46

ng/l

0.35

121

1134

Follicular cysts of skin and subcutaneous tissue

433

1.04

0.06

1.0

335.55

314.53

ng/l

0.13

309

Adverse effects, not elsewhere classified

384

1.04

0.06

1.1

1.0

319.12

332.75

ng/l

0.12

268

Fall on and from ladder

203

0.94

0.06

1.1

1.0

236.45

297.89

ng/l

0.61

136

Infections with a predominantly sexual mode of transmission

542

1.03

0.06

1.0

284.61

322.29

ng/l

0.77

389

Paroxysmal tachycardia

492

0.97

0.06

1.1

1.0

273.93

347.10

ng/l

2.30

371

Fracture of foot, except ankle

513

1.03

0.06

1.1

1.0

302.79

315.79

ng/l

0.13

370

Disorders of muscles

223

0.94

0.06

1.0

292.08

349.77

ng/l

0.82

154

Foreign body or object entering through skin

121

0.91

0.06

1.1

1.0

178.82

265.20

ng/l

2.25

Urolithiasis

910

0.98

0.05

1.0

303.19

314.73

ng/l

0.14

632

Pedal cyclist injured in other and unspecified transport accidents

243

0.95

0.05

1.0

259.00

312.62

ng/l

0.60

166

Candidiasis

314

0.96

0.05

1.0

312.83

332.60

ng/l

0.24

209

Leiomyoma of uterus

160

892

1.02

0.05

1.0

576.27

328.79

ng/l

0.59

121

640

Other spirochaetal diseases

831

1.02

0.05

1.0

305.65

328.94

ng/l

0.42

584

Disorders of calcium metabolism

149

1.07

0.05

1.0

386.80

336.45

ng/l

—

Other diseases of stomach and duodenum

159

1.07

0.05

1.0

452.17

299.79

ng/l

0.82

Tuberculosis, wide

159

1.07

0.05

1.1

1.0

249.30

316.65

ng/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

848

0.98

0.05

1.0

288.07

326.45

ng/l

0.80

594

Postmenopausal bleeding

417

1.02

0.05

1.0

297.10

339.90

ng/l

0.87

298

Glaucoma, exfoliation

252

0.95

0.05

1.1

1.0

368.46

309.87

ng/l

0.42

159

Inflammatory bowel disease treatment related agents

334

1851

1.01

0.04

1.0

292.44

330.51

ng/l

0.95

241

1319

Disorders of mineral metabolism

209

1.05

0.04

1.0

318.14

344.95

ng/l

0.11

138

Acute peritonitis

140

1.07

0.04

1.0

238.17

289.36

ng/l

—

Presbycusis

305

1.04

0.04

1.1

1.0

295.00

327.48

ng/l

0.33

186

Other diseases of pancreas

231

0.95

0.04

1.0

242.07

321.73

ng/l

1.12

161

Normotensive glaucoma

229

1.05

0.04

1.0

602.84

311.17

ng/l

0.59

149

Benign neoplasm: salivary glands, exclude unknown (D119)

231

0.95

0.04

1.0

341.64

321.30

ng/l

0.12

154

Macular hole

160

1.06

0.04

1.0

345.36

306.77

ng/l

0.28

Gonarthrosis,primary

310

1893

1.01

0.04

1.0

313.65

335.87

ng/l

0.43

215

1359

Intestinal stricture

864

1.02

0.04

1.0

271.86

335.70

ng/l

2.45

596

Malignant neoplasm of endocrine gland

170

0.94

0.04

1.0

283.73

367.81

ng/l

0.61

112

Pre-eclampsia or poor fetal growth

431

0.97

0.04

1.0

1191.58

332.62

ng/l

0.51

316

Malignant neoplasm of thyroid gland, including Hilmo

180

0.94

0.04

1.0

283.73

357.73

ng/l

0.53

119

Seborrhoeic keratosis

646

1.02

0.04

1.0

291.91

329.79

ng/l

0.68

449

Artificial joint re-operation

190

0.95

0.04

1.1

1.0

274.42

322.53

ng/l

0.56

120

Bacterial intestinal infections, IBD co-morbidities

438

1.03

0.03

1.0

286.90

328.80

ng/l

0.93

297

Suppurative and unspecified otitis media

463

0.98

0.03

1.0

274.16

307.15

ng/l

0.67

325

Disorders of vitreous body

165

1576

1.01

0.03

1.0

326.86

350.44

ng/l

0.35

120

1115

Hernia of abdominal wall, postoperative

472

0.97

0.03

1.0

252.03

336.99

ng/l

1.81

379

Benign neoplasm: Skin of other and unspecified parts of face

250

1.04

0.03

1.0

399.39

319.70

ng/l

0.37

167

Menorrhagia

425

1.02

0.03

1.0

831.17

337.38

ng/l

0.55

302

Hallux valgus (acquired)

104

737

1.01

0.03

1.0

352.90

331.93

ng/l

0.30

517

Symptoms and signs involving the skin and subcutaneous tissue

195

1925

0.99

0.03

1.0

290.99

340.79

ng/l

1.32

146

1350

Duodenal ulcer

270

1.04

0.03

1.0

315.41

324.14

ng/l

0.08

167

Other and unspecified disorders of vitreous body

140

1365

1.01

0.03

1.0

326.11

353.16

ng/l

0.37

103

961

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

679

0.98

0.03

1.0

261.49

312.97

ng/l

1.10

502

Acute upper respiratory infections

302

1872

0.99

0.03

1.0

283.83

345.22

ng/l

1.81

221

1321

Sequelae of injuries of lower limb

199

0.95

0.03

1.1

1.0

292.18

320.48

ng/l

0.23

132

Obesity related asthma

947

1.01

0.03

1.0

279.00

358.89

ng/l

1.07

669

Nutritional anaemias

135

1287

1.01

0.03

1.0

315.73

337.71

ng/l

0.38

865

Other disorders of conjunctiva

370

1.03

0.03

1.0

336.40

323.42

ng/l

0.13

248

Other local infections of skin and subcutaneous tissue

231

1.04

0.02

1.0

255.19

319.71

ng/l

1.11

154

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

239

0.96

0.02

1.0

298.50

324.34

ng/l

0.23

155

Suggestive for eosinophilic asthma

249

0.96

0.02

1.0

343.13

317.90

ng/l

0.21

170

Dyspnoea

271

1989

1.01

0.02

1.0

404.71

322.56

ng/l

0.26

187

1420

Glomerular diseases

440

0.98

0.02

1.0

343.72

321.78

ng/l

0.23

303

Complications of internal orthopaedic prosthetic devices, implants and grafts

659

1.02

0.02

1.0

277.13

338.89

ng/l

2.12

440

Iron deficiency anaemia

109

1086

0.99

0.02

1.0

329.52

334.56

ng/l

0.06

740

Other blood glucose lowering drugs, excl. Insulins

470

1.02

0.02

1.0

341.57

339.48

ng/l

0.01

314

Angina pectoris

202

1356

0.99

0.02

1.0

268.70

330.61

ng/l

4.07

141

964

Other benign neoplasms of skin

104

1028

1.01

0.02

1.0

341.64

328.86

ng/l

0.14

715

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

198

0.96

0.02

1.1

1.0

273.21

321.25

ng/l

0.82

127

Scabies

212

1.04

0.02

1.1

1.0

288.35

285.77

ng/l

0.01

145

Methotrexate

368

0.98

0.01

1.0

402.81

345.07

ng/l

0.46

264

Injury of unspecified body region

147

0.95

0.01

1.0

330.67

293.96

ng/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

163

1638

0.99

0.01

1.0

304.70

344.92

ng/l

0.61

114

1143

Viral haemorrhagic fevers, not elsewhere classified/unspecified

382

1.02

0.01

1.1

1.0

232.84

328.61

ng/l

3.78

263

Other and unspecified drugs and medicaments

187

0.96

0.01

1.1

1.0

269.31

310.19

ng/l

0.61

117

Arthropod-borne viral fevers and viral haemorrhagic fevers

432

1.02

0.01

1.0

224.82

325.30

ng/l

4.32

298

Bronchiectasis

227

0.97

0.01

1.0

328.63

331.86

ng/l

0.02

143

Bacterial pneumoniae

111

971

1.01

0.01

1.0

236.90

348.57

ng/l

8.15

670

Embedded and impacted teeth

187

0.97

0.01

1.0

217.85

285.94

ng/l

1.38

127

Other obstetric conditions, not elsewhere classified

104

1.04

0.01

1.0

276.92

259.05

ng/l

0.11

Disorders of optic nerve and visual pathways

174

1.03

0.00

1.0

305.15

306.26

ng/l

0.01

112

Other and unspecified rosacea

194

1.03

0.00

1.0

348.07

331.56

ng/l

0.08

131

Unspecified lump in breast

336

0.98

0.00

1.0

266.19

365.60

ng/l

2.16

236

Necrosis of pulp, including avohilmo

148

1476

1.00

0.00

1.0

368.92

320.54

ng/l

0.41

113

1071

Contact with and exposure to communicable diseases

397

1.00

0.00

1.1

1.0

218.20

306.97

ng/l

2.46

284

Acute suppurative otitis media

286

1.01

0.00

1.1

1.0

241.00

302.97

ng/l

1.74

191

Cutaneous abscess, furuncle and carbuncle

583

0.99

0.00

1.0

248.85

318.19

ng/l

1.60

417

Dental pulpitis, including avohilmo

247

1601

1.00

0.00

1.0

306.52

327.97

ng/l

0.25

182

1175

Sequelae with surgical and medical care as external cause

536

1.01

0.00

1.0

248.97

329.73

ng/l

2.66

366

Sequelae of external causes of morbidity and mortality

654

0.99

0.00

1.0

259.11

331.95

ng/l

2.47

448

Intestinal adhesions without obstruction

212

0.99

0.00

1.0

240.86

322.26

ng/l

1.17

145

Other and unspecified local infections of skin and subcutaneous tissue

218

1.01

0.00

1.0

255.19

322.38

ng/l

1.16

146

Superficial injury of shoulder and upper arm

238

1.01

0.00

1.0

252.59

311.85

ng/l

0.43

162

Familial hypercholesterolemia, with ischemic heart disease

262

0.99

0.00

1.0

249.22

318.34

ng/l

1.26

170

Hallux rigidus

408

1.00

0.00

1.0

387.28

338.37

ng/l

0.36

283

Other coagulation defects

129

1.01

0.00

1.0

349.25

313.24

ng/l

—

Asthma, including avohilmo

342

1917

1.00

0.00

1.0

287.16

336.89

ng/l

1.46

236

1370

Oral lichen planus, including avohilmo , including avohilmo

161

0.99

0.00

1.0

442.45

315.83

ng/l

0.54

112

Malignant neoplasm of thyroid gland

161

0.99

0.00

1.0

283.73

363.55

ng/l

0.58

105

Benign neoplasm: Parotid gland

199

1.01

0.00

1.1

1.0

341.64

311.07

ng/l

0.20

129

Artificial joint operation, meniscal resection

300

1949

1.00

0.00

1.0

345.00

330.92

ng/l

0.22

208

1395

Bacterial pneumonia, not elsewhere classified

104

916

1.00

0.00

1.0

236.35

348.37

ng/l

7.57

632

Dislocation, sprain and strain of joints and ligaments of knee

155

1431

1.00

0.00

1.0

308.22

333.22

ng/l

0.28

117

1040

Dermatographic urticaria

114

0.96

0.00

1.0

403.83

305.13

ng/l

—

conjunctival haemorrhage

194

0.98

0.00

1.0

344.00

318.71

ng/l

0.17

125

Contact with other sharp object(s)

1.02

0.00

1.0

189.60

275.20

ng/l

—

Melanocytic naevi of other and unspecified parts of face

112

0.98

0.00

1.0

343.00

314.01

ng/l

—

FESS (DNB20)

293

0.99

0.00

1.0

286.50

326.40

ng/l

0.56

205

Abrasion of teeth

914

1.00

0.00

1.0

267.30

320.86

ng/l

1.93

653

Nontoxic single thyroid nodule

168

1.01

0.00

1.0

328.08

351.04

ng/l

0.21

114

Foreign body on external eye

348

1.01

0.00

1.0

329.86

288.95

ng/l

0.21

254

Pre-eclampsia or eclampsia

372

0.99

0.00

1.1

1.0

1381.73

344.08

ng/l

0.52

273

Umbilical hernia

712

1.00

0.00

1.0

296.33

311.27

ng/l

0.21

512

Sicca syndrome [Sjögren]

199

1.01

0.00

1.0

325.27

331.51

ng/l

0.03

135

Diseases of peritoneum

249

1.00

0.00

1.0

255.29

322.87

ng/l

1.05

164

Sulfasalazine

783

1.00

0.00

1.0

328.16

330.34

ng/l

0.02

556

Benign neoplasm: Caecum

301

1.00

0.00

1.1

1.0

277.29

326.45

ng/l

0.78

197

Asthma and opportunity respiratory infection

112

0.98

0.00

1.0

306.00

326.73

ng/l

—

Mixed hyperlipidaemia

1.03

0.00

1.0

305.40

338.03

ng/l

—

Cysts of oral region, not elsewhere classified

133

0.98

0.00

1.0

363.13

290.42

ng/l

—

False labour

189

0.99

0.00

1.0

236.30

303.49

ng/l

1.32

154

Spontaneous rupture of synovium and tendon

220

1.00

0.00

1.0

377.08

352.06

ng/l

0.14

154

Other secondary coxarthrosis

1.01

0.00

1.0

898.86

303.07

ng/l

—

Chorioretinal inflammation

0.85

0.00

1.0

436.00

259.16

ng/l

—

Other congenital malformations of circulatory system

1.02

-0.00

1.0

199.60

267.13

ng/l

—

Other disorders of adrenal gland

0.90

-0.00

1.0

301.14

302.53

ng/l

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.0

—

313.40

—

Idiopathic thrombocytopenic purpura

0.98

-0.00

1.0

229.20

241.13

ng/l

—

Inflammatory disease of uterus

200

1.00

-0.00

1.0

312.07

344.63

ng/l

0.29

139

Ependymoma

0.00

-0.00

0.0

1.0

—

293.43

—

Cyst of Bartholin Gland

0.95

-0.00

1.3

1.0

293.00

353.21

ng/l

—

Brain astrocytoma

0.00

-0.00

0.0

1.0

—

293.25

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.0

—

221.20

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

298.33

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.0

—

293.25

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tau protein [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS